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The objectives of this research are: (i) to design and control pharmaceutical 
crystallization processes aimed at the selective production of metastable polymorphs, 
applicable to various types of polymorphic systems; (ii) to develop a semi-automated 
procedure for solubility measurement of both polymorphic forms, and (iii) to model 
polymorphic crystallization processes and elucidate the kinetic parameters pertaining 
to both polymorphic forms. Chapter 1 introduces several aspects of polymorphic 
crystallization, including its relevance to pharmaceutical crystallization. This will be 
followed by Chapter 2 which gives a review of recent developments particularly on the 
use of Process Analytical Technology (PAT) in this field. Chapter 3 describes the 
implementation of concentration feedback control for selective crystallization of the 
metastable polymorph in a monotropic dimorph system, using L-glutamic acid as the 
model compound. A similar demonstration is given in Chapter 5 for a different 
polymorph system, L-phenylalanine, which is an enantiotropic pseudo-dimorph 
system. Prior to this, a semi-automated scheme for solubility measurement is described 
in Chapter 4, also using L-phenylalanine as the model compound. Chapter 6 describes 
the simulation of the polymorphic crystallization processes from Chapter 5, to estimate 
the nucleation and crystal growth kinetic parameters of both forms of L-phenylalanine. 
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1 
1  GENERAL INTRODUCTION 
 
Polymorphism is the ability of a compound to adopt more than one crystal structure 
(Giron, 1995; Brittain, 1999; Davey and Garside, 2000; Beckmann, 2000; Mullin, 
2001; Bernstein, 2002; Lafferrére et al., 2003). Although chemically identical, each 
polymorph has its own unique combination of physical, thermal, and mechanical 
properties. Related to polymorphism is the crystallization of hydrates or solvates in 
which solvent molecules are incorporated into the crystal structure at well-defined 
lattice positions; these crystalline forms are called pseudo-polymorphs. The properties 
of the solvates or hydrates can vary distinctly from the primary species (Khankari and 
Grant, 1995). It has been shown that around one-third of organic substances show 
crystalline polymorphism under normal pressure conditions. A further one third are 
capable of forming hydrates and solvates (Henck et al., 1997). A list of about 450 
pharmaceutically important molecules that exhibit polymorphism has been presented 
by Borka and Haleblian (1990). 
The relative solubility of the polymorphs is indicative of their thermodynamic 
stability, the more stable polymorph having relatively lesser free energy and chemical 
potential and correspondingly lower solubility. For dimorphic systems, the solubility 
curves are classified as monotropic or enantiotropic systems. In the former, one form is 
consistently more stable (its solubility is always lower) at the given temperature range, 
while for an enantiotropic system the stability is dependent on the temperature relative 
to the point of intersection between the solubility curves (see Figure 1), which is called 
the transition temperature. Examples of monotropic systems include L-glutamic acid 
(Kitamura, 1989), chloramphenicol palmitate, and lamivudine (Grant and Gu, 2001; 
Jozwiakowski et al., 1996), while compounds such as L-phenylalanine (Mohan et al., 
2001), p-aminobenzoic acid (Gracin and Rasmuson, 2004), acetazolamide, and 
2 
metochlopramide (Giron, 1995; Griesser et al., 1997; Mitchell, 1985) are enantiotropic 
systems. 
Spontaneous nucleation in regions supersaturated with respect to both forms is 
typically of the metastable polymorph. The latter will eventually undergo phase 
transformation to the more stable modification. This is known as Ostwald’s rule of 
stages; the crystallization of the most unstable form from spontaneous nucleation, 
followed successively by forms of increasing stability, before finally arriving at the 
thermodynamic stable form. This generally holds true for both polymorphic and 
pseudo-polymorphic systems, but has its exceptions. Most transformations occur in 
suspension and are solvent-mediated. Polymorphic transformations in the dry solid 
state are less common; this is possibly due to the low mobility of the molecules, which 
is a function of temperature and the difference to the melting point (Beckmann, 2000). 










Figure 1.1 Solubility curves of dimorphs I and II (Csat,I and Csat,II respectively) in a (a) 
monotropic system and (b) enantiotropic system. 
 
The occurrence of polymorphism in a product if not properly controlled can be 









































inhibitor for human immunodeficiency virus (HIV) was stopped due to the unexpected 
occurrence of a less soluble and thermodynamically more stable polymorph 
(Chemburkar et al., 2000). The different polymorphs of the same drug compound can 
have different properties and correspondingly varying performances, for example in 
terms of the bioavailability and shelf-life of pharmaceutical compounds. It is crucial to 
have a consistent and reliable production process for the targeted polymorph to achieve 
feasible economic yield and also for regulatory compliance; a thorough evaluation of 
polymorphism is included in the New Drug Application to demonstrate control over 
the manufacturing process (Shekunov and York, 2000; Brittain, 2000).    
The stable polymorph can be obtained without much complication by allowing 
sufficient process time at suitable operating conditions, because it is 
thermodynamically stable (Doki, et al., 2004a). It is typically more difficult to produce 
the metastable polymorph in a controlled and repeatable manner; the fundamental 
challenge being to prevent cross nucleation of the unwanted stable modification 
(specifically, cross nucleation is defined as the ability of one polymorph to nucleate 
another, Tao et al., 2007). This leads to critical operational or production issue in 
circumstances where the metastable form is preferred for various reasons such as better 
handling properties, more suitable dissolution profile, and lesser impurity 
incorporation (Kitamura, 1989; Gracin and Rasmuson, 2004; Shekunov and York, 
2000; Hirayama et al., 1980).  
Recent advances utilized various process sensor technologies in the monitoring, 
design and control of pharmaceutical crystallization processes, which functions as the 
main separation and purification process for the manufacturing of drug substances. The 
aim is to reduce time to market, increase the efficiency of drug manufacturing, and 
improve product consistency; the pharmaceutical product pharmacokinetics and 
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efficiency are determined by the size distribution and the solid-state phase of the 
crystals. One notable development is the application of direct design approaches, 
which are implemented in automated systems (Fujiwara et al, 2002; Zhou et al., 2006; 
Feng and Berglund, 2005; Liotta and Sabesan, 2004; Grön et al., 2003). While 
successfully demonstrated for non-polymorphic systems, such procedures have not yet 
been applied to polymorphic systems. The application of the various in situ sensors as 
part of Process Analytical Technology (PAT) also extends towards more efficient 
measurement of useful properties such as the solubility and also in the development of 
predictive crystallization models.      
The focus of this thesis is (i) to design and control pharmaceutical crystallization 
processes aimed at the selective production of metastable polymorphs, applicable to 
various types of polymorphic systems using a direct design approach; (ii) to develop a 
semi-automated procedure for solubility measurement in polymorphic systems, and 
(iii) to model polymorphic crystallization processes and elucidate the kinetic 
parameters pertaining to both polymorphic forms.  
Chapter 2 provides a detailed literature review of recent developments in industrial 
pharmaceutical crystallization particularly on the use PAT in a direct design approach 
to design batch recipes without determining crystallization kinetics. The feasibility of 
this methodology in relation to selective crystallization is discussed along with existing 
methods of effecting preferential crystallization. A review of common techniques and 
schemes for solubility measurement and modeling studies on polymorphic 
crystallization and transformation is also given in this chapter.  
Chapter 3 describes the implementation of the direct design approach using 
concentration feedback control for selective crystallization of the metastable 
polymorph in a monotropic dimorph system, with L-glutamic acid as the model 
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compound. A similar demonstration is given in Chapter 5 for a different polymorph 
system, L-phenylalanine, an enantiotropic pseudo-dimorph system. Concentration 
feedback control was used to design a batch recipe for preferentially crystallizing the 
anhydrate form to temperatures where this form is metastable. In situ video 
microscopy was utilized for a more detailed investigation of the cross nucleation 
behavior at the metastable limit, which represents the upper boundary of the operating 
regime in the direct design approach. Prior to this, a semi-automated scheme for 
solubility measurement is described in Chapter 4, also using L-phenylalanine as the 
model compound. The procedures utilized temperature cycles and in situ 
measurements to determine conditions for saturation and complete dissolution to 
elucidate the solubility both forms in a single experiment in a more efficient manner. 
Similar to the metastable limit, the solubility represents the process boundary and is an 
important property that needs to be characterized before applying the direct design 
approach.  
Chapter 6 describes the simulation and modeling of the seeded batch crystallization 
of L-phenylalanine from Chapter 5. The crystallization model is developed based on 
the population balance equation (PBE) and the method of moments, and is used to 
estimate the nucleation and crystal growth kinetic parameters of both forms of L-
phenylalanine. Confidence interval for the parameter estimates and the validation 
exercises based on off-line characterization of the product crystals and the metastable 
limit experiments will also be discussed. Lastly, Chapter 7 reviews and concludes the 
major findings of this thesis. Potential future research direction will also be discussed 
particularly pertaining to the application of concentration feedback control in more 
complex systems such as enantiomeric systems. 
 
6 
2  LITERATURE REVIEW 
 
2.1  Direct Design of Pharmaceutical Crystallization Processes 
There has been increasing emphasis on the design, control and operation of 
pharmaceutical crystallization processes to produce a consistent crystal product (Yu et 
al., 2004). Industry batch crystallization recipes are typically based on specified 
temperature or antisolvent addition profiles, which are derived from trial-and-error 
experimentation or from nucleation and growth kinetics. The latter can be can be 
obtained through a series of continuous or batch experiments (Togkalidou et al., 2004; 
Worlitschek and Mazzotti, 2004; Miller and Rawlings, 1994; Chung et al., 2000). 
However, such approach may by time consuming particularly for complex 
crystallization systems such as aggregating or polymorphic systems, to construct 
models and determine sufficiently accurate kinetics to compute an optimal batch 
recipe. For example, a dimorphic system typically involves a half dozen expressions 
for nucleation, growth, and dissolution, and a dozen or more kinetic parameters to be 
accurately determined.     
An alternative approach is through the application of Process Analytical 
Technology (PAT), which has been gaining prominence in recent years. PAT is the 
design and control of manufacturing processes through real-time measurements with 
the goal of ensuring final product quality (Yu et al., 2004); it includes not just the use 
of in situ sensors and data analysis but also process automation, first-principles 
modeling and simulation, and design of optimized processes. A typical experimental 
apparatus for batch crystallization may utilize various in situ sensors (Figure 2.1). The 
Attenuated Total Reflection-Fourier Transform Infrared (ATR-FTIR) spectroscopy 
coupled with multivariate statistics analysis (known as chemometrics) enables accurate 
determination of the solute concentration (Fujiwara et al., 2002; Dunuwila et al., 1994; 
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Groen and Roberts, 2001; Togkalidou et al., 2001; Lewiner et al., 2001) and has been 
applied to multi-component pharmaceutical systems (Togkalidou et al., 2002). This 
technology has been widely adopted by many pharmaceutical companies, and some 
companies have applied ATR-UV spectroscopy in a similar fashion (Thompson et al., 
2005).  
Raman spectroscopy is based on the detection of changes in the energy spectrum of 
the incident radiation associated with inelastic collisions. This shift is indicative of 
changes in the molecular orientation within the crystal structure. In situ Raman 
spectroscopy can be used for the analysis of the solution phase, similar to the ATR-
FTIR spectroscopy, or to the solid phase during crystallization (Hu et al., 2005; Scholl 
et al., 2006). More importantly, in situ Raman has been used to monitor polymorphic 
phase transformation during the batch crystallization of many pharmaceutical 
compounds (Hu et al., 2005; Wang et al., 2000). It should be noted that Raman 




































Figure 2.2 Schematic of FBRM sensor. 
 
Figure 2.2 gives the schematic of the Focused Beam Reflectance Measurement 
(FBRM) sensor; it consists of a fiber optic, beam splitter, optics which rotates the laser 
beam at a high frequency, and a quartz window. When the laser beam intersects the 
particle surface, the backscattered signal is collected (via additional optics not shown 
in Figure 2.2), and is used to calculate the chord length which is the distant across the 
particle as experienced by the laser. The chord length distribution (CLD) is related to 
the particle size distribution (PSD) (Tadayyon and Rohani, 1998; Hukkanen and 
Braatz, 2003; Worlitschek et al., 2005). FBRM has been effective in detecting 
excessive nucleation events for a wide variety of pharmaceutical systems, by tracking 
the number of chords measured by FBRM per second, referred to as the total 
counts/sec (Fujiwara et al., 2002; Zhou et al., 2006). The Process Vision and 
Measurement (PVM) probe provides in situ video microscopy for characterizing 
particle shape. While the quality of PVM images varies for different systems, it is 
usually good enough to qualitatively monitor particulate characteristics such as shape 
and state of aggregation. The PVM can be used to mirror FBRM operations by placing 
the PVM probe in a mirrored position relative to the liquid surface, stirrers, and 
baffles, as that of the FBRM probe. This helps in calibrating and swiftly identifying 














flat window in an external reactor wall using an LCD camera (De Anda et al., 2005). 
This imaging technique has been shown to be effective for in-process image analysis to 
monitor polymorphic shape change of L-glutamic acid, with further applications 
extended towards quantitative size measurements of crystals (Larsen et al., 2006). 
The systematic design of batch crystallization recipes requires knowledge of the 
solubility and metastable limit, which can be determined by in situ sensors integrated 
within an automated system (Fujiwara et al., 2002; Zhou et al., 2006; Feng and 
Berglund, 2002; Liotta and Sabesan, 2004; Grön et al., 2003). The nucleation event 
associated with the metastable limit can be detected using FBRM or a turbidity probe 
and the solubility determined from ATR-FTIR spectroscopy. The area between the 
metastable limit and the solubility curve, called the metastable zone, is the appropriate 
region to operate a seeded crystallizer while avoiding excessive nucleation (Figure 2.3) 
(Fujiwara et al., 2002; Zhou et al., 2006; Feng and Berglund, 2002; Liotta and 








Figure 2.3 Direct design of a batch crystallization recipe using ATR-FTIR and FBRM. 
 
Operation near the metastable limit is likely to result in excessive nucleation and 
correspondingly higher filtration times in subsequent downstream processing, and 















































agglomeration. On the other hand, an overly conservative operation close to the 
solubility curve is not desirable because of the long batch time due to the small driving 
force. The automated direct design approach operates the batch process along several 
different supersaturation profiles and selects the trajectory with the best tradeoff. 
Operating at constant supersaturation is nearly optimal under some assumptions 
(Jones, 1974). This approach may not be exactly optimal for some systems, but is 
sufficiently close to form a good basis for the design of batch crystallizer operation. 
Using concentration feedback control based on the real-time solute concentration 
measurement from ATR-FTIR spectroscopy, the crystallizer can be operated along any 
preset supersaturation trajectory in the metastable zone (Fujiwara et al., 2002; Zhou et 
al., 2006; Liotta and Sabesan, 2004). Concentration feedback control differs from a 
typical temperature feedback control operation in terms of the setpoint specifications. 
In the latter, the batch recipe is in terms of a temperature (T) versus time (t) setpoint 
profile, as defined by the user. In concentration feedback control, while the main setup 
is similar to the standard temperature feedback control, the temperature setpoint is 
calculated based on a preset supersaturation profile. The supersaturation is defined as 
∆C = C – Csat, where C is the solute concentration and Csat is the solubility. Replacing 
C with the measured solute concentration (Cmeas) and an algebraic function for Csat as a 
function of T gives 
 
Csat(T) =  Cmeas – ∆C                     (2.1) 
 
Solving for T gives the temperature setpoint. In other words, in concentration feedback 
control, the batch recipe in this case takes the form of a concentration trajectory 
expressed as a function of temperature. This approach can also be applied in 
antisolvent crystallization by substituting T with % solvent (Zhou et al., 2006).  
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This approach requires no crystallization kinetics and does not require controller 
tuning except at a lower level to track the reactor temperature or antisolvent addition 
rate (which can be done by most commercially available water baths or solvent 
pumps). Its simplicity greatly reduces the time needed to develop a recipe for batch 
crystallization. This has been successfully applied in non-polymorphic systems and 
further work based on simulations and experiments have shown that this control 
implementation using concentration versus temperature recipes is more robust against 
variation in growth or nucleation kinetics and practical disturbances, than temperature 
versus time recipes (Zhou et al., 2006; Fujiwara et al., 2005; Nagy et al., 2008; Yu et 
al., 2006).  
 
2.2  Direct Design of Pharmaceutical Polymorphic Crystallization Processes 
There are numerous past accounts in literature on operating conditions (for 
example, in terms of critical seed loading (Doki et al., 2004a), fines dissolution (Doki 
et al., 2004b), additives (Mohan et al., 2001; Davey et al., 1997), sonication (Gracin et 
al., 2005), microemulsion (Yano et al., 2000), and solvent selection (Garti et al., 
1980a; Sato et al., 1985; Profir and Rasmuson, 2004; Mirmehrabi and Rohani, 2005; 
Trifkovic and Rohani, 2007)) necessary for the selective crystallization of the 
metastable form. The implementation is often system or property specific and its 
suitability in other polymorphic systems is unknown.  
Other methods of selective crystallization involve determining cooling temperature 
or solvent addition profiles, typically specified with other process conditions such as 
agitation rate, temperature range, and initial concentration, by trial-and-error 
experimentation. A recipe could alternatively be obtained by optimization of a 
population balance model with solubilities and kinetics for the specific system, but this 
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approach can be time-consuming for complex polymorphic/pseudo-polymorphic 
systems, as mentioned earlier. 
A strategy for selective crystallization based on the solubility diagrams is more 
generic and does not require information of the crystallization kinetics not trial-and-
error experimentations (Beckmann, 2000; Gracin and Rasmuson, 2004; Lewiner at al., 
2001; Fujiwara et al., 2005; Threlfall, 2000; Lin et al. 2007). These strategies are based 
on seeding locations or spontaneous nucleation of the targeted form in its occurrence 
domain (Sato and Boistelle, 1983) and more importantly, following a specified 
trajectory in the phase diagram so that the combined effects of desaturation due to 
crystal nucleation and growth and supersaturation due to cooling or antisolvent 
addition do not drive the solute concentration into the domains of spontaneous 
nucleation of the undesired forms (Beckmann, 2000; Gracin and Rasmuson, 2004; 
Threlfall, 2000; Lin et al. 2007). 
For a monotropic system with two different positions for the metastable limit, the 
thermodynamically stable polymorph, Form II, could be selectively produced by 
operating from x to y as shown in Figure 2.4a. An undersaturated solution is cooled 
from x, seeded with Form II crystals after crossing its solubility curve, Csat,II, and 
cooled with the supersaturation profile below the metastable limit to y, which avoids 
uncontrolled nucleation. Alternatively, Form II can also be obtained by following a 
supersaturation profile below the Form I solubility curve (Lin et al., 2007), Csat,I, while 
exceeding the metastable limit. As this operation is still between the solubility curves, 
the resulting nucleation produces only Form II; this does not affect polymorph purity 
although it does widen the product size distribution. Seeding and controlled growth of 
the metastable polymorph, Form I, is not possible for a system as in Figure 2.4a 
(Beckmann, 2000; Lin et al. 2007). With the metastable limit between the solubility 
13 
curves, it is difficult to produce crystals with high polymorph purity for Form I in 
regions supersaturated with respect to this form, due to the high likelihood of 
nucleating some unwanted Form II once the metastable limit is crossed.  
The production of highly pure Form I crystals is much more promising for a 
monotropic system with characteristics as shown in Figure 2.4b. Form I can be 
obtained by operating from x to y with seeding of Form I just after crossing its 











Figure 2.4 Schematic of selective crystallization operations for (a) Form II and (b) Form I, in a 



































































Figure 2.5 Schematic of selective crystallization operations for Form I, in an enantiotropic 
dimorph system based on the solubility diagram with different metastable limits. 
 
Figure 2.5 shows schematics for enantiotropic dimorph systems with different 
metastable limits encountered during cooling (similar schematics apply in antisolvent 
crystallization). Form I which is stable above and metastable below the transition 
temperature can be selectively produced by operating from x to y; an undersaturated 
solution at x is cooled, seeded with Form I crystals after crossing the solubility curve 
for Form I, Csat,I, and cooled with the supersaturation profile below the solubility curve 
of Form II, Csat,II, to y (Threlfall, 2000; Lin et al. 2007). The region between the 
solubility curves above the transition point is supersaturated with respect only to Form 
I, thus cross nucleation of Form II is not possible. Such operations however have 
limited yield which is proportional to the difference in the initial and final solute 
concentration, due to the restricted operating temperature range. However if the 
metastable limit is known, the operating temperature range can be extended (and 
correspondingly increasing the yield) by following x to z, operating the crystallizer 
such that the supersaturation is below the metastable limit (Threlfall, 2000) to avoid 

















































The schematics in Figures 2.4 and 2.5 show only a single metastable limit instead 
of one for each form (Threlfall, 2000) because it is very difficult to determine 
experimentally two distinct metastable limits for some systems (Threlfall, 2003). The 
schematics illustrated here with a single metastable limit provide a more pragmatic 
representation. Crossing the metastable limit in regions supersaturated with respect to 
both forms could potentially nucleate either or even concomitant forms depending on 
the process conditions such as the solvent type, temperature range, and seed form. 
Such operations should be avoided if selective growth of a polymorphic form is 
desired. The above techniques rely on early seeding with the targeted form, as opposed 
to relying on nucleation of that form. The crystallization operations described above in 
Figures 2.4 and 2.5 have been presented as hypothesized methodologies (Beckmann, 
2000; Gracin and Rasmuson, 2004; Threlfall, 2000; Lin et al. 2007) but lack 
comprehensive experimental investigations (Gracin and Rasmuson, 2004; Lewiner at 
al., 2001; Lin et al. 2007).  
Central to the implementation of such operations is the control of the cooling or 
antisolvent addition rate to balance desaturation due to crystallization and increased 
supersaturation caused by cooling or other means, so that the supersaturation profile 
remains within a specified region of the phase diagram. Concentration feedback 
control has the capability to operate the crystallization to follow the desired 
concentration profile. While successfully applied to non-polymorphic systems 
(Fujiwara et al., 2002; Zhou et al., 2006; Feng and Berglund, 2002; Liotta and 
Sabesan, 2004; Grön et al., 2003) the direct design approach with concentration 
feedback control has not yet been demonstrated in polymorphic systems; this sets the 
main motivation of this research. In the efficient design of robust and reliable 
crystallization processes for complex systems, a more integrated approach based on 
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underlying physical mechanisms is needed rather than by trial-and-error 
experimentation. Designing and controlling pharmaceutical polymorphic 
crystallization processes is an area where the implementation of more advanced control 
strategies can have a large impact. 
 
2.3  Techniques for Solubility Measurement 
Due to its influence on bioavailability, solubility in particular is important in the 
development of polymorphic drug compounds (Haleblian and McCrone, 1969; 
Higuchi et al., 1963). In addition, the relative solubility of the polymorphs is indicative 
of their thermodynamic stability. Particularly for enantiotropic dimorph systems, the 
transition temperature is important for drug development (Grunenberg, et al., 1996) 
because the suitable form for development and subsequent production should be 
decided based on thermodynamic stability. The transition temperature can be estimated 
by linear extrapolation of van’t Hoff plots for each polymorph to find the point of 
intersection (Umeda et al., 1985; Behme and Brooke, 1991) or by using the heats of 
solution and solubility data (Urakami et al., 2002). Establishing the solubility diagrams 
of polymorphic systems is also important for selective crystallization of specific 
polymorphs, as described earlier.  
The solubility is commonly determined using gravimetric techniques; a known 
amount of solid is added to a specific amount of solvent in an equilibrium cell (for 
example, a jacketed vessel) and maintained at a fixed temperature with constant 
stirring for sufficient time to reach equilibrium. The solubility is then calculated by 
subtracting the weight of the remaining solid phase (isolated by filtration) from its 
initial mass (Mohan et al., 2001). The solubility can also be determined from the 
filtered liquid samples by solvent evaporation and measuring the weight of the ‘dry 
residue’ mass (Gracin and Rasmuson, 2004; Ono et al., 2004). Alternatively, liquid 
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samples from equilibrated slurries can be evaluated with high-performance liquid 
chromatography (HPLC) systems (Luk and Rousseau, 2006; Maruyamaa et al., 1999). 
These methods have been applied in polymorphic systems such as L-phenylalanine 
(Mohan et al., 2001), L-glutamic acid (Ono et al., 2004a), p-aminobenzoic acid 
(Gracin and Rasmuson, 2004), L-serine (Luk and Rousseau, 2006), and taltireline 
(Maruyamaa et al., 1999). Mohan et al. (2002) and Young and Schall (2001) utilized 
Differential Scanning Calorimetry (DSC) to estimate the solubility from heat flow 
curves (Mohan et al., 2002; Young and Schall, 2001). A disadvantage of these 
approaches is that the solubility at each temperature point is determined through 
individual experiments, typically carried out by manual procedures. The replication of 
the manual steps increases the risks of introducing experimental errors in the 
determination of the solubility curves.  
Several other workers (Fujiwara et al., 2002; Grön et al., 2003; Scholl et al., 2006) 
measured the solute concentration in situ by using Attenuated Total Reflectance-
Fourier Transform Infrared (ATR-FTIR) spectroscopy, and the solubility was 
determined similarly based on the IR spectra of equilibrated slurries. The preliminary 
step was to construct the calibration model using the IR spectra of known solutions. 
The calibration, which was rooted in the Beer-Lambert law, quantified the linear 
relationship between absorbance and solute concentration and was used to calculate 
solute concentration of unknown slurries. In Grön et al. (2003), the calibration model 
was constructed by defining the intensity ratio of relevant ATR-FTIR spectra peaks as 
a calibration parameter which relates to both solute concentration and temperature. 
Togkalidou et al. (2001a) constructed the calibration model using chemometrics which 
is a class of multivariable statistical algorithms. The procedure constructed different 
calibration models using various chemometrics techniques such as principal 
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component regression (PCR) and partial least squares (PLS) and the model that 
produced the most accurate predictions was selected. These approaches reduce manual 
labor and materials as different solubility points can be determined from the same 
experimental set-up by changing the equilibrium temperature. The measurement errors 
can be quantified in terms of the accuracy of the chemometrics predictions 
(Togkalidou et al., 2001a).  
There has also been increasing interest in developing automated procedures to 
determine the solubility in a more efficient manner (Liotta and Sabesan, 2004; Barrett 
and Glennon, 2002; Parsons et al., 2003; Yi et al., 2005); these have been 
demonstrated for non-polymorphic systems. One of the objectives of this research is to 
develop such schemes for polymorphic systems.     
 
2.4  Modeling of Polymorphic Crystallization and Transformation 
The direct design approach reviewed and proposed for selective crystallization 
processes in polymorphic systems, in Sections 2.1 and 2.2 do not require information 
on the crystallization kinetics. However, crystallization kinetics are useful for further 
optimization of the operating conditions, specifically to elucidate the combined effect 
of process conditions such as the temperature profile, supersaturation, seeding 
conditions, etc. Additionally, process simulations of polymorphic crystallization 
facilitate the understanding of the possible crystallization mechanisms, including that 
of cross nucleation. The estimation of the relevant kinetic parameters in the 
relationship for crystal nucleation, growth and dissolution of the polymorphs can be 
achieved through the use of population balance modeling of relevant experimental data 
of both the solid and liquid phase.  
Cardew and Davey (1985) modeled the solvent-mediated transformation based on 
supersaturation data. The following kinetic expressions (for the dissolution of the 
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metastable polymorph 2 and growth of the stable polymorph 1) were used along with 
an overall mass balance equation relating supersaturation and the crystal sizes. 
 
2 , ,1/ ( )d r sat rdL dt K C C=− ∆ −∆             (2.2) 
 
1 ,1/ g rdL dt K C= ∆              (2.3) 
 
,1 ,1 ,1( ) /r sat satC C C C∆ = −             (2.4) 
 
, ,2 ,1 ,1( ) /r sat sat sat satC C C C∆ = −            (2.5) 
 
,2 ,2 ,/D in d r satL K C= ∆τ          (2.6) 
 
,1 ,1 ,/G fn g r satL K C= ∆τ             (2.7) 
 
where L is the crystal size, the subscripts 1 and 2 denote forms 1 and 2 respectively 
while in and fn indicate the initial and end of the transformation. The authors also 
introduced time constants associated with the growth and dissolution processes. In the 
case of a dissolution-limited transformation, the transformation time can be 
approximated by the dissolution time τD,2 (defined as the time required for all the 
metastable crystals to dissolve at their maximum dissolution rate). The second limiting 
type of transformation occurs when the growth rate of the stable polymorph is so slow 
that the dissolution of the metastable polymorph easily maintains the supersaturation 
close to its solubility until all the metastable polymorph crystals are dissolved. In the 
latter, the transformation time is approximated by τG,1 (defined as the time taken for the 
stable polymorph crystals to reach their final size at their maximum growth rate). The 
model predicts that a plateau supersaturation and a shoulder should characterize the 
desaturation profiles because the growth and dissolution processes are balanced as 
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some stage in the transformation. The value of the plateau supersaturation is shown to 
be a measure of the kinetic constants kG and kD and the relative surface areas of both 
polymorphs. The value of such modeling work is the mechanistic insights that it 
provides, as corroborated in subsequent experimental results from other researchers, 
for example in the α to β transformation of L-glutamic acid (Kitamura, 1989; Garti and 
Zour, 1997) where the growth of the stable β-form crystals was found to be the rate 
limiting step.  
Earlier experimental studies on polymorphic crystallization and transformation 
utilized offline characterization of samples withdrawn at certain intervals throughout 
the duration of the experiment to measure properties such as solute concentration, 
polymorph composition, and crystal morphology (Mohan et al., 2001; Maruyamaa et 
al., 1999; Garti and Zour, 1997). More recent works had the benefits of using a wider 
array of experimental instruments, particularly in providing real-time measurements 
such as solute concentration through ATR-FTIR (Scholl et al., 2006; Hermanto et al., 
2008) chord length distribution through laser backscattering (Scholl et al., 2006; 
Hermanto et al., 2008) and polymorphic composition through Raman spectroscopy or 
x-ray diffraction (Hu et al., 2005; Scholl et al., 2006; Wang et al., 2000; Ono et al., 
2004b). The application of PAT allows thorough investigation in terms of more 
comprehensive monitoring which facilitates subsequent modeling work. Most 
experimental investigations were on the solvent-mediated transformation, which 
considered only the dissolution of the metastable phase and the nucleation and growth 
of the stable phase. Such studies have been carried out on both monotropic and 
enantiotropic systems (Hu et al., 2005; Wang et al., 2000; Ono et al., 2004a; Caillet et 
al., 2007; Starbuck et al., 2002; Qu et al., 2006; Caillet et al., 2006). Considerably 
fewer studies focused on the crystallization kinetics of both polymorphic forms; 
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previous reports have been presented for a monotropic system (Groen and Roberts, 
2001; Scholl et al., 2006; Hermanto et al., 2008). While such analysis is more 
complex, it provides more meaningful information on the optimization of polymorphic 
crystallization processes. The last part of this thesis presents the simulation of 
polymorphic crystallization for an enantiotropic pseudo-dimorph system to elucidate 
the crystallization kinetics of both forms. To the best of the author’s knowledge, this is 



















3  SELECTIVE CRYSTALLIZATION OF THE METASTABLE 
POLYMORPH IN A MONOTROPIC DIMORPH SYSTEM 
 
3.1  Introduction 
 This chapter describes the application of the concentration feedback control 
methodology based on the phase diagram operations pathways reviewed in the 
previous chapter, for the selective crystallization of the metastable polymorph in a 
monotropic dimorph system. L-glutamic (L-glu) acid in water was used as the model 
system. L-glu acid consists of a five-carbon backbone, two carboxylic groups, and an 
amino group; it is relatively soluble in water. The isoelectric point of this amino acid is 
at pH 3.22, while it has net negative charge at pH 7. Industrially, this compound has a 
high annual production volume and is use primarily as a food additive and in 
pharmaceuticals (Garti and Sato, 1986; Black et al., 1986). 
L-glu acid crystals have two known polymorphs, α and β forms, which are 
monotropically related (Kitamura, 1989). The metastable α-form has a prismatic 
(Figure 3.1a) or granular morphology if precipitated at low supersaturation (Kitamura, 
1989), while the stable β-form crystallizes as needlelike platelets (Figure 3.1b). In 
industrial processing, the α-form is preferred as it is easier to handle in subsequent 
downstream operations (Hirayama et al., 1980). Numerous papers have studied the 
polymorphic transformation behavior of L-glu acid (Kitamura, 1989; Scholl et al., 
2006; Ono et al., 2004a; 2004b; Garti and Zour, 1997; Ni et al., 2004). At 45oC or 
higher, excess amounts of the α-form in a saturated aqueous solution will transform 
into the stable β form. The transformation is solvent-mediated and consists of two 
steps: the dissolution of the α-form and the nucleation and growth of the β-form, which 
is the rate-determining step (Kitamura, 1989). The transformation has a strong 
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temperature dependence (Kitamura, 1989; Ono et al., 2004a; 2004b) with slower 









Figure 3.1 Scanning electron micrographs of L-glu acid crystals (scale bar 100 µm): (a) α-form 
and (b) β-form. 
 
A previous study in the preferential crystallization of the metastable polymorph 
utilized additives to stabilize this form through conformational mimicry for L-glu acid 
(Davey and Blagden, 1997). This work aims to demonstrate the direct design approach 
using concentration feedback control as a more generic strategy for such processes 
applicable to other monotropic systems. Specifically, the objective is to achieve 
selective crystallization of metastable α-form crystals with large uniform size. The 
lower and upper bounds of the operating region were specified by the α-form solubility 
curve and metastable limit, respectively. Attenuated Total Reflectance-Fourier 
Transform Infrared (ATR-FTIR) spectroscopy coupled with a calibration model 
constructed using chemometrics techniques (Workman et al., 1996; Mobley et al., 
1996; Bro et al., 1997) was used to provide in situ solute concentration measurement. 
Focused Beam Reflectance Measurement (FBRM), which measures in situ the 
characteristics of crystal size distribution, was used to detect the metastable limit, as 
(b) (a) 
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previously demonstrated (Fujiwara et al., 2002; Barrett and Glennon, 2002; Tahti et al., 
1999) for the seeded system. The seeded batch cooling crystallizations were 
implemented with concentration feedback control at different supersaturation profiles 
to obtain the most appropriate batch recipe for selectively growing metastable L-glu 
acid crystals. Section 3.2 gives a detailed description of these experimental procedures; 
the corresponding results and discussion are provided in Section 3.3. A summary of the 
key findings are given in Section 3.4.     
 
3.2  Experimental Procedures 
3.2.1  Materials and Instruments 
A schematic of the instrumentation setup for the crystallization experiments is 
given in Figure 2.1. A Dipper-210 ATR immersion probe (Axiom Analytical) with 
ZnSe as the internal reflectance element attached to a Nicolet Protégé 460 FTIR 
spectrophotometer was used to obtain the aqueous L-glu acid spectra. A setting of 64 
scans was used for each FTIR spectra. Degassed deionized water at 23.0oC was used 
for the background measurement. Chord length distributions of L-glu acid crystals in 
solution were measured every 20 seconds using Lasentec FBRM (model, M400L) with 
version 6.0b12 of the FBRM Control Interface software. The Lasentec Particle Vision 
and Measurement (PVM) instrument probe was not utilized for the study in this 
chapter.  
The solution temperature was controlled by ratioing hot and cold water to the 
jacket with a control valve using IMC-PID control (Braatz, 1995; Morari and Zafiriou, 
1989) and was measured every 2 sec using a Teflon-coated thermocouple attached to a 
Data Translation 3004 data acquisition board via a Fluke 80TK thermocouple module.  
Powder X-ray diffraction (PXRD) patterns of the L-glu acid crystals were collected 
offline, using the Bruker General Area Detector Diffraction System (GADDS, Bruker 
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AXS, Inc.) with Cu Kα1 and Cu Kα2 (weighted sum) radiation and step size 0.02°. The 
characteristic peaks of both forms in the PXRD patterns (Figure 3.2) are consistent 
with Scholl et al. (2006).  
L-glu acid crystals obtained commercially (99%, Sigma Aldrich) were verified by 
PXRD measurements to be β-form; the characteristic peaks of the α-form were absent. 
α-form crystals used for solubility measurement and as seeds in the metastable limit 
and batch crystallizations experiments were obtained from rapid cooling (Ono et al., 
2004a; 2004b), and the purity similarly verified using PXRD. Scanning Electron 
Microscopy (SEM) samples were sputtered with 4-8 nm of Au/Pd before being 












































Figure 3.3 Representative ATR-FTIR spectra of the calibration samples and regression 
coefficients of the calibration model relating absorbance to solute concentration (the regression 
coefficients for the temperature and the intercept are not shown). 
 











Cs1 0.00837 33.7 – 21.0 21 
Cs2 0.01301 48.0 – 23.3 40 
Cs3 0.01800 56.7 – 32.3 40 
Cs4 0.02300 64.0 – 34.1 49 
Cs5 0.02800 63.9 – 45.3 31 
 
3.2.2  Calibration for Solution Concentration  
Different solute concentrations of L-glu acid in 400 g deionized water (Table 3.1) 
were placed in a 500 ml jacketed round-bottom flask and heated until all the crystals 
dissolved. The solution was agitated with an overhead mixer with a stirring speed of 
250 rpm. The solution was cooled at 0.5 oC/min, while the IR spectra were collected. 
The measurements were stopped once crystals started to appear. The IR spectra of 












































Cs1, 25.3 °C 
Cs2, 33.1 °C 
Cs3, 41.3 °C 
Cs4, 49.6 °C 





At the given frequency range, the largest positive regression coefficient was 
observed at 1400–1405 cm-1 (Figure 3.3). This corresponded to the largest peak which 
was due to the carboxylate stretching band in the IR spectra. The calibration model 
relating the IR spectra and temperature to solute concentration was determined using 
various chemometrics methods such as principal component regression (PCR) and 
partial least squares regression (PLS) (Togkalidou et al., 2001a; 2001b; 2002). The 
calculations were carried out using in-house MATLAB 5.3 (Mathworks, Inc) code 
except for the PLS method, which was from the PLS Toolbox 2.0. The mean width of 
the prediction interval was used as the criterion to select the most accurate calibration 
model. The noise level of 0.001 was selected based on the compatibility of the 
prediction interval with the accuracy of the solubility data. The forward selection PCR 
2 method (Xie and Kalivas, 1997) was selected which gave the smallest prediction 
interval. The prediction interval (±0.00037 g/g solvent, with a confidence interval = 
95%) was comparable with the deviations of the experimental data points from the 







C w a w T w
=
= + +∑              (3.1) 
 
where C is the solute concentration (g/g solvent), aj is the absorbance at frequency j 
cm-1, T is the temperature (°C), and wj, wT, and w0 are regression coefficients. 
 
3.2.3  Solubility and Metastable Limit Measurements 
For each polymorph, the IR spectra of L-glu acid slurries were collected at 
different temperatures ranging from 25.0 to 60.0 °C. The slurry was equilibrated for 45 
min to 1 hour at each evaluated temperature point before recording the IR spectra.  
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The equilibrium solute concentration was then calculated using the aforementioned 
calibration model. The allocated time was deemed sufficient for equilibration as the 
recorded solute concentration profile did not show any further changes, indicative of 
saturation. The measurements were performed twice at the evaluated temperature 
points.  
The metastable limit of L-glu acid solutions was determined at various solute 
concentrations as listed in Table 3.2, using the polythermal method (Nyvlt et al., 
1985). Each solution was heated to 5.0°C above its saturation temperature and 
maintained at 1 hr, before cooling at 0.4 °C/min. As the main crystallization 
experiments utilized seeding, the metastable limit was determined for the seeded 
system; α-form seed crystals (0.23 g, 100-300 µm) were added at 2.0°C after the 
solution temperature crossed the α-form saturation temperature. The chord length 
distributions of the crystals in solution were monitored using FBRM.  
The start of a sharp increase in the total number of measured chords (total 
counts/sec), after seeding (Figure 3.4) was considered to be the onset of secondary 
nucleation at the metastable limit which was then plotted based on the solute 
concentration and temperature corresponding to the time points when the nucleation 
events were detected in all five experiments. No weighting of the total counts/sec 
profile was used. Square- and volume-weighting of the total counts tended to give 
delayed detection of nucleation, while 1/length weighting was more susceptible to 
background noise. In both the solubility and metastable limit experiments, the solvent 





Table 3.2 Initial solute concentrations in the metastable limit experiments. 
 
Run 
Initial solute concentration,  
g/g solvent 
1m 0.01590 
2m 0.01722; 0.01719 
3m 0.01868 










Figure 3.4 Total counts/sec (-) and temperature (x) profiles in the metastable limit experiment. 
 
 
3.2.4  Seeded batch crystallization  
Appropriate amounts of L-glu acid in deionized water (400 g) was heated to an 
initial temperature of 55.0°C (5.0°C above the β-form saturation temperature) to create 
an undersaturated solution with solute concentration 0.02000 g/g solvent. The stirring 
conditions were the same as that used previously. The crystallizer was then cooled at 
0.4 °C/min to 39.5°C (2.0°C below the α-form saturation temperature), upon which α-
form seed crystals were added. The mass and size distribution of the seeds were similar 
to that in the metastable limit experiments. The seed mass, msd, represented a seed 
loading ratio /sd ym m  of about 0.09, where my is the expected yield. Preset 












































feedback control based on in situ solute concentration measurement as described 
previously. The control algorithm was started shortly after seeding. Supersaturation 
setpoint profiles were selected at different constant absolute supersaturation, ∆Cα = C 
– Csat,α, and relative supersaturation, ∆Cr,α =  ∆Cα/Csat,α, with respect to the α-form, 
where Csat,α (g/g solvent) is the solubility of the α-form. A preliminary run was carried 
out similarly at constant ∆Cα but at a higher initial solute concentration, 0.02800 g/g 
solvent, with correspondingly higher operating temperature range, where initial and 
seeding temperature were at 65.0 and 48.3 °C, respectively. 
 
3.3  Results and Discussion 
3.3.1  Solubility and Metastable Limit Measurements  
The solubility curves of both α and β-forms of L-glu acid are in good agreement 
with available solubility data (Figure 3.5a) (Ono et al., 2004a). The largest discrepancy 
for the α-form amounted to -0.00025 g/g solvent (-2.3%) while that for the β-form was 
0.00058 g/g solvent (2.1%). The dissimilarities for the β-form were statistically 
significant as they exceeded the prediction interval of the calibration model. The 
difference in solubility can be attributed to differences in the purity of the solute and 
solvent used. The solubility curves were fit to  
 
, 0, 1,exp( )sat i i iC b b T=                 (3.2) 
 
where i denotes α or β-forms and Csat,i (g/g solvent) is the solubility (see Table 3.3). 
The maximum deviation of the experimental data points from the fitted solubility 
curves (-0.00033 and 0.00037 g/g solvent for the α and β-forms respectively) were 
comparable with the prediction interval. The solubility measurement of the metastable 
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form using the above method applies only if the dissolution of this form is relatively 
faster than its transformation to the stable form so that equilibrium with respect to the 
metastable form is achievable, as is the case of L-glu acid for the studied temperature 
range (Scholl et al., 2006). 
 





b0,i 4.208 × 10
-3 3.555 × 10-3 
b1,i 3.767 × 10
-2 3.460 × 10-2 
 
To determine the metastable limit of the seeded system, a cooling rate of 0.4 
°C/min was sufficiently fast to cool an undersaturated solution (region 1 in Figure 
3.5b) across both solubility curves (into region 3) to achieve supersaturation with 
respect to the α-form, with no significant nucleation until the metastable limit was 
reached. This provided a window (region 3) to seed and grow α-form crystals in a 
controlled manner. Further cooling (into region 4) would increase the driving force to 
grow the seed crystals but uncontrolled secondary nucleation would occur once the 
metastable limit is crossed.  
The metastable limit provides an estimate of the maximum allowable 
supersaturation for the selective and controlled growth of α-form seed crystals without 
any uncontrolled secondary nucleation. Using cooling rates lower than 0.4 °C/min led 
to primary nucleation before any seeding opportunity, either in region 2 or very close 
to Csat,α in region 3. Primary nucleation in region 2 resulted in β-form crystals, while 
that in region 3 produced both forms. In either case, unintended primary nucleation is 
detrimental to the selective and controlled growth of the α-form seed crystals in terms 















Figure 3.5 L-glu acid solubility curves compared to: (a) previously published data (Ono et al., 
2004a) and (b) metastable limit for cooling rate at 0.4 °C/min. 
 
3.3.2 Concentration Controlled Batch Crystallization 
The supersaturation profile for a preliminary seeded concentration controlled batch 
crystallization carried out at higher temperatures with ∆Cα at 0.00320 g/g solvent is 
shown in Figure 3.6a, with the temperature range upon seeding from 48.3 to 39.0°C 
(Figure 3.6b).  
Although the FBRM total counts/sec did not show an appreciable increase, needle-
shaped β-form crystals were observed on the surfaces of some α-form product crystals 
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       Csat,α (Ono et al., 2004a)  
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L-glu acid crystals (Cashell et al., 2003a; 2003b; Ferrari and Davey, 2004). The cross 
nucleation and growth of the β-form on α-form crystal surfaces did not generate 
significantly more ‘independent’ particles, such that this nucleation event was not 
detected by FBRM. Compositional analysis based on the PXRD pattern (Figure 3.7) 


























































































Figure 3.6 Preliminary seeded batch crystallization run: (a) implemented supersaturation 
profiles, (b) temperature profile (seeding at 0 min), and (c) microscopy image of the α-form 













Figure 3.7 PXRD patterns of the seed and product crystals. 
 
 
Table 3.4 PXRD analysis of seed and product crystals. 
 
Sample 
Estimated solid composition*  
(wt % β-form) 
Seeds 0.48 (σ = 0.14), 0.23 (σ = 0.13); average = 0.36 
High temperature run products 7.55 (σ = 0.18), 7.78 (σ = 0.15); average = 7.67   
Run 1 products 0.00 (σ = 0.16), 0.43 (σ = 0.14); average = 0.22  
Run 2 products 1.37 (σ = 0.13), 1.08 (σ = 0.18); average = 1.23 
Run 3 products 0.96 (σ = 0.12), 1.03 (σ = 0.16); average = 0.93 
*The polymorph composition was calculated using a convolution-based profile-fitting 
algorithm available in the Diffracplus Topas (version 3.0, AXS Bruker Inc.) software, 
based on lattice parameters and atomic coordinates (Hirayama et al., 1980; Lehmann et 
al., 1972). Both α and β-forms are orthorhombic with space group P212121 (Hirayama 
et al., 1980; Lehmann et al., 1972).  
8 12 16 20 24 28 32 36 40
Run 3 products 
Run 2 products 
Run1 products 
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Subsequent experiments utilized a lower operating temperature range, 39.5 to 25.0 
°C, to avoid cross nucleation of β-form crystals. Runs 1 and 2 were carried out with 
∆Cα at 0.00420 and 0.00320 g/g solvent, respectively, and Run 3 at ∆Cr,α = 0.212 
(Figure 3.8a). The supersaturation profiles for Runs 2 and 3 remained in the metastable 
zone throughout the duration of the experiment, while that of Run 1 crossed the 
metastable limit initially and stayed very close to it for the remainder of the run. The 
impact of using different supersaturation profiles can be observed from the FBRM 
total counts/sec profiles (Figure 3.8c).  
In Run 1, an increase in the total counts/sec was observed due to secondary 
nucleation associated with the excessive supersaturation. For Run 2, the total counts 
remained nearly constant except for an increase towards the end (~100 min onwards). 
The increase in the total counts/sec in the late stages of Run 2 is consistent with earlier 
findings that secondary nucleation tends to increase with crystal mass (Zhou et al., 
2006; Randolph and Larson, 1988).  
Maintaining constant ∆Cr,α (decreasing ∆Cα) in Run 3 compensated for the effect 
of increasing crystal mass, to greatly suppress secondary nucleation. The recipe for 
Run 3 was designed following the magnitude of ∆Cr,α in Run 2 prior to the onset of 
secondary nucleation (before 100 min). Solid composition analysis using PXRD 
patterns indicated significantly lower amounts of the β polymorph in the products of 
Runs 1, 2, and 3 as compared to the preliminary high temperature batch run (Table 
3.4). For this temperature range and seeding conditions, the increase in the total 

























Figure 3.8 Seeded batch crystallization Runs 1-3: (a) implemented supersaturation profiles, (b) 
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Figure 3.9 Microscopy images of seed and product crystals (scale bar 180 µm): (a) α-form seed 
crystals, (b) α-form product crystals from Run 1 with wide size variation, (c) α-form product 
crystals from Run 1 with agglomeration, (d) α-form product crystals from Run 2, and (e) α-




















Figure 3.10 Size distribution of L-glu acid α-form seeds (based on the largest diagonal length 
measurable from the microscopy images) and product crystals (based on dimension indicated 
in Figure 3.9e); sample size of 100 crystals for each distribution. 
 
The change in the crystal habit of the seed from rhomboid to hexagonal (with 
increase in the thickness of the crystal, see Figure 3.9) was consistent with past reports 
of α-form growth (Kitamura and Ishizu, 2000). The product crystals of Runs 2 and 3 
which had little or no secondary nucleation were of fairly uniform size (300-600 µm), 
as opposed to Run 1 (see Figure 3.10). Agglomeration was also observed for the Run 1 
product crystals (Figure 3.9c). The best batch recipe implemented with concentration 
feedback control was that of Run 3 which gave high polymorph purity and narrow 
product size distribution. The polymorph purity in Run 3 as assessed by inspection of 
microscopy images and by PXRD was not statistically distinguishable from pure α-
form crystals (Table 3.4). 
In comparison to the rapid cooling method used to obtain the α-form seeds, 
homogenous nucleation is highly sensitive to local operation conditions and is often 
hard to reproduce (Ono et al., 2004a; 2004b). A nucleation-based approach for 
selective crystallization has less reproducibility in terms of polymorph purity of the 
product and is less efficient particularly if there is a targeted product size range, 
compared to the above concentration feedback control approach based on suppression 
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polymorphic system, it is important to consider the cross nucleation behavior, which in 
this case prohibited the use of higher temperatures in the selective growth of the 
metastable α-form seed crystals. The temperature range utilized in Runs 1-3 was 
successful in maintaining high polymorph purity. β-form secondary nucleation was 
averted by selecting a lower temperature range where it was known to be significantly 
less dominant, while α-form secondary nucleation was suppressed by avoiding 
excessive supersaturation.  
Additionally, the results from Runs 2 and 3 suggest that the metastable limit 
described a practical upper bound of the operating regime in the initial stages of 
crystallization, but less so towards the end due to the effect of increasing crystal mass 
on promoting secondary nucleation. The cooling rate used in the metastable limit 
experiments was similar to that in the initial stages (prior to seeding) in the 
concentration controlled experiments. Upon seeding and starting concentration 
feedback control, the cooling rates (Figure 3.8b) ranged from 0.05-0.15, 0.04-0.12, and 
0.03-0.07 °C/min for Runs 1, 2, and 3, respectively. As the experiment progressed, 
there were increasing dissimilarity in the operation conditions (specifically the mass of 
crystals and the cooling rate) between the metastable limit experiments and the 
concentration controlled runs, and the upper bound identified in the former was no 
longer representative of the actual conditions in the latter. Nonetheless, appropriate 
batch crystallization recipes can be designed systematically based on constant relative 
supersaturation ∆Cr,α, using the results of earlier constant absolute supersaturation 
∆Cα recipes as a more appropriate indication of the upper bound, to effectively prevent 
secondary nucleation in the later stages of the operation. The overall approach in 
designing the batch recipe is to set Run 1 as the most aggressive near the metastable 
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limit, while Run 2 can be set to a smaller supersaturation intended to be a ‘tuning’ run. 
However, the smallest difference between Runs 1 and 2 is limited by the accuracy of 
the solute concentration calibration model.   
 
 
3.4  Concluding Remarks 
In this chapter, a batch recipe for the selective crystallization with uniform crystal 
size of the metastable form of a monotropic dimorph system, L-glutamic acid in water, 
was identified through direct design. The solubility curves of both α and β-forms were 
determined using ATR-FTIR spectroscopy, combined with chemometrics. Laser 
backscattering was used to determine the seeded metastable limit. Various preset 
supersaturation profiles were followed during crystallization using concentration 
feedback control to adjust the cooling rate accordingly based on in situ solute 
concentration measurements. Undesired α-form secondary nucleation at the metastable 
limit as well as β-form secondary nucleation at high temperatures, provided the 
operating constraints in terms of the maximum allowable supersaturation and operating 
temperature range, respectively, for the selective crystallization of metastable α-form. 
Batch crystallization below 40.0°C at constant relative supersaturation suppressed both 
types of secondary nucleation and was successful in selectively growing large 
metastable crystals with uniform size. These results suggest that this may be a generic 







4  SEMI-AUTOMATED SOLUBILITY MEASUREMENT FOR AN 
ENANTIOTROPIC PSEUDO-DIMORPH SYSTEM 
 
4.1 Introduction 
For pharmaceutical compounds, the solubility is critical property because of its 
influence on bioavailability (Haleblian and McCrone, 1969; Higuchi et al., 1963). 
Particularly for polymorphic compounds, the relative solubility is indicative of the 
thermodynamic stability of the different modifications, a key parameter in 
pharmaceutical development. Knowing the solubility diagram is also important for 
selective crystallization processes, as described in Chapters 3 and 5.    
There has been an increased interest in a more automated approach to reduce the 
time and labor involved in solubility measurements. Liotta and Sabesan (2004) and 
Barrett and Glennon (2002) used in situ laser backscattering (Focused Beam 
Reflectance Measurement, FBRM) to determine the solubility, based on the number of 
measured chords (total counts), which is characteristic of the number of particles in the 
slurry. By slowly increasing the temperature of a slurry of known solute concentration, 
the saturation temperature can be determined as the point where the total counts 
decrease to zero indicating complete dissolution (Liotta and Sabesan, 2004). In Barrett 
and Glennon (2002), the temperature at zero counts was plotted against different 
heating rates, and the saturation temperature was determined by extrapolation to an 
infinitely slow heating rate. Both of these studies presented an automated scheme of 
measuring the solubility and metastable limit for a non-polymorphic system, through 
sequential cooling (to induce primary nucleation at the metastable limit) and heating 
(to detect the saturation at the point of complete dissolution). Turbidity probes have 
also been utilized in similar manner (Parsons et al., 2003), more recently as part of a 
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semi-automated system based on simultaneous measurements of transmission versus 
temperature profiles from parallel experiments (Yi et al., 2005).  
This chapter demonstrates a semi-automated approach to determining the solubility 
of both forms of L-phenylalanine (L-phe) in water using Attenuated Total Reflectance-
Fourier Transform Infrared (ATR-FTIR) spectroscopy, coupled with chemometrics, 
and FBRM in a single experiment. Such an approach has been demonstrated for non-
polymorphic systems (Zhou et al., 2006; Liotta and Sabesan, 2004; Barrett and 
Glennon, 2002); to the best of the authors’ knowledge, this work is the first to present 
such an application for an enantiotropic dimorph system.  
L-phe consists of a nine-carbon backbone, a carboxylic and an amino group as well 
as a benzyl size chain. The isoelectric point of this amino acid is at pH 5.5. It is an 
essential amino acid and is use as a pharmaceutical and food intermediate (Mohan et 
al., 2001). It is an enantiotropic pseudo-dimorph system where the anhydrate crystals, 
also denoted as the β-form (Yano et al., 2000; Khawas, 1985), appear as platelets 
(Figure 4.1a) and is stable above the transition temperature of 37.0oC (Mohan et al., 
2001). The monohydrate form, also denoted as the α-form (Yano et al., 2000; Khawas, 
1985) appears as very fine needles (Figure 4.1b). Because the monohydrate needles 
were of dimensions comparable to the penetration depth of the IR energy field into the 
solution (≈1.0-2.0 µm in this study), there was significant solid phase interference on 
the IR measurements, making it difficult to determine its solubility solely using ATR-
FTIR spectroscopy. For most cases, the penetration depth of the IR energy field is 
smaller than the liquid phase barrier between the probe and the particles such that the 
substance in immediate contact with the probe is the liquid phase of the slurry, with 
negligible interference from the crystals, as it was for the anhydrate form crystals. A 
detailed description of these experimental procedures is provided in Section 4.2, while 
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Section 4.3 gives the corresponding results and discussion. Section 4.4 presents the 




















Figure 4.1 Microscopy images of L-phe crystals: (a) anhydrate form as is from Sigma Aldrich 
(>98.5%), (b) monohydrate form, and (c) the anhydrate form with a more well-defined habit as 
rhombic platelets obtained through recrystallization. 
 
 
4.2  Experimental Procedures 
4.2.1  Materials and Instruments 
The instrumentation setup for the crystallization experiments was identical to that 
in the previous chapter (Section 3.2.1). Aqueous L-phe spectra were obtained by an 








23.5oC was used for the background measurement. The chord length distribution of L-
phe crystals in solution were measured every 20 sec using Lasentec FBRM. In 
addition, in situ images of the slurry were obtained using the Lasentec Particle Vision 
and Measurement (PVM model 700L) instrument. The solution temperature was 
controlled in the same manner as that described in the previously. All experiments 
were performed similarly under these instrument conditions.  
Powder X-ray diffraction (PXRD) patterns of L-phe crystals were collected offline 
using the Bruker General Area Detector Diffraction System (GADDS, Bruker AXS, 
Inc.) with Cu Kα1 and Cu Kα2 (weighted sum) radiation and step size 0.02°. The 
anhydrate form is orthorhombic while the monohydrate form is monoclinic; the space 
group is P2221 for both (Mohan et al., 2001; Khawas, 1985). Figure 4.2 shows PXRD 
patterns for both forms of L-phe; the characteristic peaks are consistent with a previous 
report (Mohan et al., 2001). L-phe crystals obtained commercially (>98.5%, Sigma 
Aldrich) were verified using PXRD to be pure anhydrate form; the characteristic peaks 
of the monohydrate form were not observed. These anhydrate form crystals were used 
in the experiments without further purification.  
The monohydrate crystals were produced by rapidly cooling an initially 
undersaturated solution (0.045 g/g solvent) from 60 to 25°C. The crystals were filtered, 
dried at 30oC, and stored at room temperature with the polymorphic form confirmed 
using PXRD. The drying and storage temperatures have been previously verified to be 
sufficiently low such that it did not lead to the dehydration of the monohydrate crystals 





4.2.2  Calibration for Solute Concentration 
Different solute concentrations of L-phe and ultrapure water (approx. 400 g) were 
placed in a 500-ml jacketed round-bottom flask and heated until all the crystals 
dissolved, with the solution agitated by an overhead mixer with a stirring speed of 250 
rpm. Table 4.1 lists the calibration samples. The solution was cooled at 0.5 oC/min 
while the IR spectra were collected. The measurements were stopped once crystals 
started to appear. The IR spectra in the range 1300-1415 cm-1 and the temperature were 
used to construct the calibration model. Figure 4.3 compares the representative IR 

















Figure 4.3 Representative ATR-FTIR spectra of the calibration samples and regression 
coefficients of the calibration model relating absorbance to solute concentration. The 













































Cs1, 23.9 °C 
Cs2, 33.1 °C 
Cs3, 41.9 °C 
Cs4, 51.4 °C 























Solute concentration   





Cs1 0.02407 26.9 – 19.5 12 
Cs2 0.03004 38.9 – 23.0 22 
Cs3 0.03702 49.9 – 35.0 20 
Cs4 0.04402 60.8 – 43.1 22 
Cs5 0.05025 67.6 – 51.0 19 
 
The calibration model which relates the IR spectra and temperature to solute 
concentration was determined as described previously (Togkalidou et al., 2001a) using 
various chemometrics methods. The calculations were carried out using in-house 
MATLAB 5.3 (The Mathworks, Inc) code except for partial least squares (PLS) 
regression, which was from the PLS Toolbox 2.0. The chemometrics method 
correlation PCR (Togkalidou et al., 2001b; Xie and Kalivas, 1997) with a noise level 
of 0.001 was selected which gave the smallest prediction interval of ±0.00051 g/g 
solvent (with a confidence level = 95%), while being consistent with the accuracy of 
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=
= + +∑             (4.1) 
 
where C is the solute concentration (g/g solvent), aj is the absorbance at frequency j 
cm-1, T is the temperature (°C), and wi, wT, and w0 are regression coefficients. 
 
4.2.3  Solubility Measurements 
The solubility of both forms of L-phe was determined using two methods. In 
Method 1, the solubility for each form was determined separately through addition of 
excess crystals of a specific form to create a saturated slurry, while in the semi-
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automated approach denoted as Method 2, the solubility of both forms was determined 
from a single experiment. The solvent mass used in both methods was approx. 400 g, 
and the stirring speed of the overhead mixer was maintained at 300 rpm. To shorten 
the time required to achieve saturation, anhydrate form crystals of smaller sizes (< 250 
µm) were used. 
Method 1 – Solubility measurements from separate experiments. For the anhydrate 
form, the IR spectra of the slurry were collected at different temperature points ranging 
from 25 to 60°C. The solute concentration profile was tracked using the 
aforementioned calibration model, and the required equilibration time at each 
evaluated temperature point was decided based on the total counts/sec profile 
measured by FBRM. The equilibrium solute concentration was first determined at a 
low temperature and the slurry temperature was increased in stages to determine the 
solubility at higher temperatures. When necessary, more anhydrate form crystals were 
added in excess so that saturation can be achieved at all the evaluated temperature 
points.  
For the monohydrate, the solubility could not be determined from the equilibrated 
slurry due to significant solid phase interference on the IR measurements which 
resulted in erroneous measurement even at low slurry density. Instead, the slurry was 
heated slowly at 0.1 °C/min after equilibration, while tracking the solute concentration 
and total counts. The saturation temperature and the corresponding solute 
concentration were determined at the lowest temperature (at the earliest time point) 
where the profiles approached a constant value, indicating complete dissolution. The 
solubility can be determined reliably using the above approach only if the heating rate 
was sufficiently slow relative to solid dissolution such that the slurry was always in 




























completely dissolved corresponded to the saturation temperature. In a preliminary 
experiment, different heating rates were evaluated to ensure that the heating rate used 
in the solubility measurement was sufficiently slow to maintain equilibrium. At low 
heating rates, 0.1 and 0.2 °C/min, the counts fell to the ‘baseline’ value at the same 
temperature, while higher temperatures were observed at larger heating rates (Figure 
4.4). The initial mass of monohydrate form crystals in the slurry equilibrated at 21°C 
was identical in these four runs. This showed that heating rate of 0.1 °C/min was 
sufficiently slow relative to dissolution, such that equilibrium was maintained as the 
temperature increased. The solubility measurements were performed twice for each 








Figure 4.4 Total counts/sec profiles as a function of temperature at different heating rates. The 
non-zero baseline value was due to the presence of bubbles caused by the high stirring rate. 
 
Method 2 – Single-experiment semi-automated approach. The solubility of the 
anhydrate form at the initial temperature was determined from a slurry in a similar 
manner to Method 1. The slurry was then heated to dissolve all the excess anhydrate 
crystals, and the solution was cooled to a sufficiently low temperature. Small amounts 
of monohydrate form seed crystals were added to induce the nucleation of this form. 
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Upon sufficient crystallization of the monohydrate form, the slurry was heated at 0.1 
°C/min, and the solubility was determined upon complete dissolution as in Method 1. 
The cycle was repeated at higher temperatures after addition of anhydrate crystals to 
make a slurry. 
 
4.3  Results and Discussion 
4.3.1  Method 1  
For the anhydrate form, the solubility was determined from in situ solute 
concentration measurement of slurry equilibrated at various temperatures. For 
example, Figure 4.5 shows the solute concentration and total counts/sec profiles of a 
slurry containing anhydrate form L-phe crystals initially equilibrated at 30°C, 
approaching saturation after two temperature ramps to 35 and 40°C. The plateau in 
counts/sec reached after 30 min in both cases was taken as indicative of saturation. 
This corresponded to solute concentration 0.03505 and 0.03777 g/g solvent at 35 and 
















































































Figure 4.5 (a) Solute concentration and temperature profiles and (b) total counts/sec profile in 





















Figure 4.6 (a) Solute concentration and temperature profiles and (b) total counts/sec profile in 
the solubility experiment for monohydrate form L-phe using Method 1. The open circles 

































































































The solubility of the monohydrate form was determined from slow heating of 
equilibrated slurry due to interference of the monohydrate form crystals on the IR 
measurements. As the monohydrate slurry was heated at 0.1 °C/min, the counts/sec 
initially decreased due to dissolution of the solid phase (Figure 4.6), and the amount of 
interference on the ATR probe also reduced. When the solid phase was completely 
dissolved, the solute concentration was correctly estimated. The equilibrium solute 
concentration was determined at the lowest temperature (which would be the saturation 
temperature) where both the concentration and counts did not exhibit further changes 
due to complete dissolution. The solubility was 0.03920 g/g solvent and the 
temperature at this time point (approx. 28 min) was 42.8°C.  
The next slurry was prepared by adding more monohydrate form crystals at 62 
min. After equilibration, the same heating rate was applied. The saturation temperature 
was detected at 47.6°C (at approx. 78 min) and the corresponding solute concentration 
was 0.04349 g/g solvent. The estimated equilibrium solute concentration in both cases 
was consistent with that calculated based on the total crystal mass added into the 
slurry. The solubility of monohydrate form was determined at other temperatures in 
similar manner.  
As shown in Figure 4.7, there is good agreement between the solubility curves of 
both forms of L-phe determined using Method 1 with available solubility data (Mohan 
et al., 2001). The largest discrepancy for the anhydrate form amounted to only -
0.00092 g/g solvent (-1.8%) while that for the monohydrate form was 0.00053 g/g 
solvent (1.1%). Although the dissimilarities are statistically significant given that they 
exceeded the prediction interval of the calibration model, it could be attributed to 










Figure 4.7 L-phe solubility curves compared to previously published data (Mohan et 
al., 2001) for the anhydrate form, Csat,a, and monohydrate form, Csat,m. 
 
The solubility curves were fit to 
 
2
, 0, 1, 2,sat i i i iC b b T b T= + +             (4.2) 
 
where i denotes anhydrate or monohydrate form and Csat,i (g/g solvent) is the solubility 
(Table 4.2). The maximum deviation of the experimental data points from the fitted 
solubility curves (0.00050 and -0.00049 g/g solvent for the anhydrate and monohydrate 
forms, respectively) were within the prediction interval. 
 








(Mohan et al., 
2001)  
Monohydrate form 
- this study 
Monohydrate 
form – literature 
(Mohan et al., 
2001)  
b0,i 1.854 × 10
-2 2.043 × 10-2 2.595 × 10-2 1.949 × 10-2 
b1,i 3.890 × 10
-4 2.394 × 10-4 -3.188 × 10-4 5.169 × 10-5 
b2,i 1.987 × 10



































       Csat,a (this study) 
       Csat,a (Mohan et al., 2001)  
       Csat,m (this study) 
       Csat,m (Mohan et al., 2001) 
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4.3.2  Method 2  
The semi-automated approach (Method 2) combined both procedures in Method 1 
to measure the solubility of both forms of L-phe in a single-experiment. Figure 4.8 
illustrates two operation cycles in the low and middle temperature range for this 
approach.  
In Cycle 1, the solubility of the anhydrate form was determined from an 
equilibrated slurry (part a) similar to that described in Method 1. The system was then 
heated to dissolve the anhydrate form (part b) and cooled to generate supersaturation to 
nucleate the monohydrate form (part c). Seed crystals were added to ensure nucleation 
of the correct form as well as to expedite the recrystallization process. Upon sufficient 
recrystallization, the slurry was heated at 0.1 °C/min and the solubility was determined 
at the point of complete dissolution (part d), similar to that described in Method 1.  
The slurry was then heated to the initial temperature for Cycle 2, and excess 
amount of the anhydrate crystals was added before starting this cycle. The solute 
concentration, temperature, and counts/sec profiles during both cycles are shown in 
Figures 4.9 and 4.10. The first plateau in the concentration and total counts/sec profiles 
in part (a) (similar to that in Figure 4.5) indicates saturation of the anhydrate crystal 
















Figure 4.8 Schematic of Method 2 and L-phe solubility points using Method 2 compared to the 











Figure 4.9 Solute concentration, anhydrate form   ( ) and monohydrate form ( ), and 
temperature (+) profiles in the solubility experiment using Method 2. The concentration profile 
is not shown entirely for parts (c) and (d) because of erroneous measurement due to 
interference from monohydrate needles. The open circles indicate erroneous concentration 



























































































        Csat,a (Method 2) 
       Csat,a (Method 1) 
       Csat,m (Method 2) 














Figure 4.10 Total counts/sec profile in the solubility experiment using Method 2 with the 
anhydrate form (-) referencing the left axis and the monohydrate form (-) referencing the right 
axis. 
 
The subsequent plateau in part (b) corresponds to complete dissolution of 
anhydrate solids upon heating to 35°C. Subsequent cooling to 23°C and seeding with 
small amounts of monohydrate crystals resulted in the nucleation of this form, 
indicated by the increase in the total counts in part (c). At the start of heating in part 
(d), the total counts continued to increase because the slurry was still supersaturated, 
but decreased eventually when solids dissolved with increasing temperature. The 
lowest temperature at which the solute concentration (0.03013 g/g solvent) did not 
exhibit further changes due to complete dissolution was taken as the saturation 
temperature, 30.6°C. The total counts/sec (Figure 4.10) fell to a constant value upon 
reaching the saturation temperature, similar to Figure 4.6.  In situ video microscopy 
images (Figure 4.11) were monitored to ensure that crystals of the correct polymorph 
were obtained during solubility measurements. 
Similar analysis for Cycle 2 based on the three profiles gave solubilities of 0.03497 
g/g solute at 36.0°C (anhydrate form) and 0.03935 g/g solvent at 42.8°C (monohydrate 
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(Figure 4.7). Other solubility points were determined in the same manner at different 
temperatures. This solubility measurement of the metastable form (i.e., anhydrate and 
monohydrate forms below and above the transition temperature, respectively) should 
apply provided that its dissolution is significantly faster than its transformation to the 
stable form, so that equilibrium with respect to the metastable form is achievable. This 
occurs for the L-phe for the studied temperature range (Mohan et al., 2001), has been 
observed in other polymorphic systems (Scholl et al., 2006), and is expected to be 
fairly common since nucleation of the stable form from a slurry of metastable crystals 
requires crossing energy barriers to molecular ordering whereas dissolution does not. 
In this semi-automated procedure, the temperature cycle was automated by 
following a pre-programmed profile, and the addition of excess anhydrate crystals and 
monohydrate seeds were performed manually at various stages of the sequence. This 
was necessary to produce a slurry containing only a single polymorph in a reasonable 
time. Previous works (Liotta and Sabesan, 2004; Barrett and Glennon, 2002) on fully 
automated approaches in non-polymorphic systems relied on primary nucleation to 
create a slurry, but this form of nucleation may not be feasible for polymorphic 
systems because it may lead to concomitant polymorphs.  
The procedure allowed the solubility determination of both forms in a single 
experiment, reducing time and labor. This is also advantageous because handling of 
recrystallized solid phases is minimized to reduce the risk of dehydration, especially 





















Figure 4.11 PVM images from the solubility experiment using Method 2 (scale bar 100 µm): at 
the anhydrate form saturation, the recrystallization of the monohydrate form, and the eventual 
dissolution. 
 
4.4  Concluding Remarks 
In this chapter, a semi-automated procedure for measuring the solubility of both 
enantiotropes in a dimorphic system in a single experiment was developed using ATR-
FTIR spectroscopy for in situ measurement of solute concentration and FBRM to 
measure the total counts. This was applied to enantiotropic pseudo-dimorph L-
phenylalanine. The solubility of the anhydrate form was determined by measuring the 
solute concentration isothermally at saturated conditions. The time required to reach 







concentration and total counts/sec profiles. Due to significant interference from the 
solid phase on the IR measurement, the solubility of the monohydrate form was 
determined from the dissolution of the slowly heated monohydrate slurry. The 
saturation temperature and the corresponding solute concentration were determined at 
the lowest temperature where the total counts/sec and solute concentration profiles 
approached a constant value, indicating complete dissolution. This approach requires 


















5  SELECTIVE CRYSTALLIZATION OF THE METASTABLE 




This chapter describes the application of the concentration feedback control 
methodology based on the phase diagram operations pathways reviewed in Chapter 2, 
for the selective crystallization of the metastable polymorph in an enantiotropic 
dimorph system. L-phenylalanine (L-phe) in a mixed solvent (water and 2-propanol) 
was used as the model system. Figure 5.1 shows the scanning electron micrographs of 
the two crystalline forms: the anhydrate form, which appears as rhombic platelets, and 









Figure 5.1 Scanning electron micrographs of L-phe crystals: (a) anhydrate form and (b) 
monohydrate form. 
 
Yano et al. (2000) utilized reversed micelles in the preferential crystallization of 
the anhydrate form; additives such as ammonium sulfate can also be used to increase 






transition temperature (Mohan et al., 2001). This work aims to demonstrate the direct 
design approach using concentration feedback control as a more generic strategy for 
such processes applicable to other enantiotropic system. Specifically, the objective is 
to selectively crystallize the anhydrate form in a seeded system to a temperature below 
the transition point, where this form is metastable. The lower and upper bounds of the 
operating regime are specified by the anhydrate form solubility curve and metastable 
limit, respectively.  
Similar to Chapter 3, Attenuated Total Reflection-Fourier Transform Infrared 
(ATR-FTIR) spectroscopy coupled with a calibration model constructed using 
chemometrics techniques (Workman et al., 1996; Mobley et al., 1996; Bro et al., 1997) 
was used to provide in situ solute concentration measurement. Focused Beam 
Reflectance Measurement (FBRM) was used to detect the metastable limit (Fujiwara et 
al., 2002; Barrett and Glennon, 2002; Tahti et al., 1999); the nucleated form was 
assessed using in situ video microscopy. The seeded batch cooling crystallizations 
operations were implemented with concentration feedback control at different 
supersaturation profiles to obtain an appropriate recipe for selectively growing 
anhydrate L-phe crystals. Section 5.2 provides a detailed description of these 
experimental procedures, while Section 5.3 gives the corresponding results and 
discussion. A summary of the key findings is given in Section 5.4. 
 
5.2 Experimental Procedures 
5.2.1 Materials and Instruments 
The instrumentation setup for the crystallization experiments was identical to that 
in the two preceding chapters (Sections 3.2.1 and 4.2.1). Aqueous L-phe spectra were 
obtained by an ATR immersion probe attached to a FTIR spectrophotometer. The 
chord length distribution of L-phe crystals in solution were measured every 30 sec 
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using Lasentec FBRM. In addition, in situ images of the slurry were obtained using the 
Lasentec Particle Vision and Measurement (PVM) instrument. The solution 
temperature was controlled in the same manner as that described in the previously. 
Powder X-ray diffraction (PXRD) patterns of L-phe crystals were collected offline 
using the Bruker General Area Detector Diffraction System (GADDS, Bruker AXS, 
Inc.) with Cu Kα1 and Cu Kα2 (weighted sum) radiation and a step size of 0.02°. The 
characteristic peaks for the anhydrate form are at 5.54°, 22.70°, 28.40°, and 34.24° 
while that for the monohydrate form are at 6.38°, 8.90°, 14.76°, and 27.70° (Figure 
4.2).  
Recrystallized anhydrate crystals were used in the metastable limit and batch 
crystallization experiments as seeds because these had a well-defined rhombic shape as 
opposed to the commercially available crystals, which were irregular platelets. The 
recrystallization procedure involved initially cooling undersaturated solution (0.030 
g/g mixed solvent) from 50 to 42oC, then adding monohydrate crystals. The solvent-
mediated transformation of the monohydrate to the anhydrate form was completed 
after about 2.5 hours under isothermal conditions and constant stirring. The mixed 
solvent which consisted of 75 wt% deionised water and 25 wt% 2-propanol (ACS 
grade, Sigma Aldrich) was used instead of pure water. This was to increase the density 
difference between the liquid and solid phase, and prevent solids accumulation on the 
liquid surface. The PXRD pattern of the recrystallized anhydrate form was identical to 
that obtained commercially indicating that the recrystallized form was the same 
polymorph with a different crystal habit. The monohydrate form was produced 
following the method previously discussed in Section 4.2.1. Similar rapid cooling 
procedures using the mixed solvent also resulted in the crystallization of the 
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monohydrate form. Scanning Electron Microscopy (SEM) samples were sputtered with 
4-8 nm of Au/Pd before being recorded with a JEOL 7000F SEM. 
 
5.2.2  Calibration for Polymorph Composition using PXRD 
PXRD patterns of the powdered samples of L-phe crystals with different 
polymorph compositions prepared using a mortar and pestle were used to create a 
calibration for polymorph composition (Figure 5.2). A linear calibration line was 
constructed by plotting the peak intensity ratio (6.38° and 8.90° for the monohydrate; 























Figure 5.2 (a) PXRD patterns of calibration samples (the largest peak at 2θ ≈ 5.54° was 
normalized to the same value in all the patterns to better illustrate the variation in the 
characteristic peaks of the monohydrate form), and (b) PXRD calibration line for polymorph 
composition. 
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Mass fraction  
(wt% monohydrate) 
Estimated mass fraction 
(wt% monohydrate) 
1 0.00 0.00 
2 0.00 1.12 
3 0.00 0.00 
4 20.1 22.4 
5 20.1 24.3 
6 40.3 39.7 
7 40.3 42.9 
8 60.5 61.7 
9 60.5 54.6 
10 80.7 80.3 
11 80.7 81.3 
 
5.2.3 Calibration for Solute Concentration  
Different solute concentrations of L-phe (Table 5.2) in the mixed solvent (400 g, 
75 wt% deionized water and 25 wt% 2-propanol) were placed in a 500-ml jacketed 
round-bottom flask and heated until all the crystals dissolved. An overhead mixer was 
used to agitate the solution with a stirring speed of 175 rpm. The solution was cooled 
at 0.5 oC/min while the IR spectra were collected until crystals started to appear. The 
IR spectra in the range 1100–1650 cm-1 were used to construct the calibration model. 
Figure 5.3 compares representative IR spectra of L-phe solutions used for calibration 


















Cs1 0.01503 29.0 – 19.1 16 
Cs2 0.01903 34.0 – 20.1 22 
Cs3 0.02303 42.1 – 22.0 31 
Cs4 0.02700 47.9 – 32.8 24 









Figure 5.3 Representative ATR-FTIR spectra of the calibrations samples and regression 
coefficients of the calibration model relating absorbance to solute concentration. The 
regression coefficients for the temperature and the intercept are not shown. 
 
The calibration model relating the IR spectra and temperature to solute 
concentration was determined using various chemometrics methods (Togkalidou et al., 
2001a; 2001b; 2002). The calculations were carried out using in-house MATLAB 5.3 
(Mathworks, Inc.) code except for partial least squares (PLS) regression, which was 
from the PLS Toolbox 2.0. The mean width of the prediction interval was used as the 
criterion to select among calibration models. The forward selection PCR 2 (FPCR 2) 
method (Xie and Kalivas, 1997) with a noise level of 0.001 gave the smallest 


































Cs1, 25.2 °C 
Cs2, 30.3 °C 
Cs3, 35.0 °C 
Cs4, 40.1 °C 















compatible with the deviation of the experimental data points from the fitted solubility 







C w a w T w
=
= + +∑             (5.1) 
 
where C is the solute concentration (g/g solvent), aj is the absorbance at frequency j 
cm-1, T is the temperature (°C), and wi, wT, and w0 are regression coefficients. 
 
5.2.4  Solubility and Metastable Limit Measurements 
For each form, the IR spectra of L-phe slurries were collected at different 
temperatures while equilibrating for 30 min to an hour, with solute concentration 
determined using the aforementioned calibration model. The time needed for 
equilibration was determined from the point when the total number of chords (total 
counts) measured by FBRM remained constant (within the measurement noise). Care 
was taken to ensure that the monohydrate form crystal slurry contained only a small 
amount of excess solids, to prevent significant solid phase interference on the IR 
measurements. Such interference may occur when the crystal dimensions are 
comparable to the penetration depth of the IR energy field, particularly in slurries with 
high solid density. The measurements were performed twice for each evaluated 
temperature point. The monohydrate form solubility was also evaluated in a second 
method in which an equilibrated slurry of monohydrate form crystals was heated very 
slowly at 0.1 °C/min. The heating rate was sufficiently slow relative to dissolution that 
equilibrium was always maintained as the temperature increased. The saturation 
temperature and the corresponding solute concentration were determined at the lowest 
temperature (at the earliest time point) in which the concentration and total counts/sec 
profiles approached a constant value, indicating complete dissolution. 
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The metastable limit of L-phe solutions was determined for various initial solute 
concentrations (Table 5.3) using the polythermal method (Nyvlt et al., 1985). Each 
solution was heated above its saturation temperature to dissolve all crystals before 
cooling at 0.1 °C/min. As the main crystallization experiments utilized seeding, the 
metastable limit was determined for the seeded system; anhydrate crystals (0.50 g, 
220-520 µm) were added at 0.6°C after the solution temperature crossed the anhydrate 
form saturation temperature. Upon seeding, PVM images were collected to check for 
the appearance of the monohydrate needles and the chord length distribution of the 
crystals was monitored using FBRM. The start of a sharp increase in the total 
counts/sec some time after seeding was considered to be a nucleation event. In both the 
solubility and metastable limit experiments, the solvent mass and composition as well 
as the stirring speed of the overhead mixer were similar to that for calibration. 
 
Table 5.3 Initial solute concentrations in the metastable limit experiments. 
 
Run 








5.2.5  Seeded Batch Crystallization 
Appropriate amounts of L-phe and 400 g of the mixed solvent were heated to 
above the saturation temperature of the anhydrate form to create an undersaturated 
solution with solute concentration 0.023 g/g solvent. The solvent composition and the 
stirring condition were the same as that used for calibration. The solution was then 
cooled at 0.1 °C/min to 0.6°C below the saturation temperature of the anhydrate form 
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upon which anhydrate seed crystals with similar size distribution as that in the 
metastable limit experiments were added. The seed mass (0.51, 0.49, and 0.46 g for 
Runs 1, 2, and 3 respectively) represented an average seed loading of ~15% based on 
the expected yield. Preset supersaturation profiles were followed during crystallization 
using concentration feedback control (Fujiwara et al., 2002; Zhou et al., 2006) to adjust 
the cooling rate accordingly based on in situ solute concentration measurements. The 
control algorithm was started shortly after seeding. Supersaturation setpoint profiles 
were selected at different constant absolute supersaturation (∆Ci = C – Csat,i) with 
respect to both the anhydrate and monohydrate forms where Csat,i denotes the solubility 
(g/g solvent) of the ith form, either the anhydrate (a) or monohydrate (m).  
 
5.3  Results and Discussion 
5.3.1  Solubility and Metastable Limit Measurements 
The solubility curves for both forms of L-phe in the mixed solvent were fit to 
 
2
, 0, 1, 2,sat i i i iC b b T b T= + +              (5.2) 
 
(see Table 5.4 and Figure 5.4). The maximum deviation of the experimental data 
points from the fitted solubility curves (0.00031 and 0.00034 g/g solvent for the 
anhydrate and monohydrate forms, respectively) were within the prediction intervals.  
The solubility of the monohydrate form was evaluated using two methods: 
equilibrated slurries at isothermal conditions (similar to that for the anhydrate form) 
and subjected to slow heating. The solubility studies in the previous chapter using 
slurries of monohydrate form L-phe crystals in water reported significant solid phase 
interference on the IR measurements leading to excessively higher and erroneous 
solute concentration predictions even at low solids density. This was likely due to the 
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dimensions of the monohydrate form crystals which were comparable to the 
penetration depth of the IR energy field (≈1.0-2.0 µm, in that study).  
However, in the water/2-propanol system, the interference on the IR measurements 
was not significant at low solids density as verified by the identical solubility results 
(see Figure 5.4) obtained using the second method in which the equilibrium solute 
concentration was measured at the point of complete dissolution. The negligible 
interference at low solid density was possibly due to the change (albeit minor) in the 
effective refractive index of the slurry and correspondingly in the IR energy field 
penetration depth with the addition of 2-propanol in the solvent. However, the 
interference is likely to become progressively significant as the solid density of the 
monohydrate form crystals increases.  
Compared to L-phe in water, a decrease in the transition temperature from 37.0 to 
26.5°C was observed in the mixed solvent. This was also reported for L-serine (in 
water-methanol solutions) (Luk and Rousseau, 2006), which has similar pseudo-
dimorph behavior. The van’t Hoff plots in that study showed that the decrease in the 
transition temperature was due to a greater difference in the entropy of dissolution 
compared to the enthalpy of dissolution between the two forms with the addition of 
methanol in the solvent. 
 
 




Anhydrate form Monohydrate form 
b0,i 6.351 × 10
-3 5.866 × 10-3 
b1,i 2.218 × 10
-4 9.474 × 10-5 
b2,i 7.502 × 10












Figure 5.4 Solubility curves of L-phe: Csat,a (  ) and Csat,m (  ) in a mixed solvent from 
isothermal studies, Csat,m (  ) in a mixed solvent from slow heating. 
 
The seeded metastable limit was determined using FBRM to detect secondary 
nucleation and in situ video microscopy to identify the nucleated form. At 
temperatures below the transition point, for example in Run 2m, monohydrate needles 
were observed at 41 min, which was before the increase in FBRM total counts/sec at 
52 min (see Figures 5.5 and 5.6). The first limit determined via PVM images 
represents the onset of cross nucleation. Noise in the FBRM measurements resulted in 
its later detection of nucleation. Above the transition point, for example in Run 4m, 
needles were not detected prior to or at the onset of increase in total counts/sec at 43 
min (see Figures 5.7 and 5.8) but were only observed at a later time (at 63 min); this 
indicates that the nucleation detected via FBRM was that of the seeded anhydrate 
form. Unlike the monohydrate form, the anhydrate form was not easily detected using 
PVM until after its detection via FBRM, most likely due to the low number density of 
the nucleated crystals of the anhydrate form. The seeded metastable limit associated 
with both types of secondary nucleation shown in Figure 5.9 provides an estimate of 
the maximum allowable supersaturation for the controlled growth of the anhydrate 




































nucleation of the seeded form, which would affect the crystal size distribution of the 

















Figure 5.5 Run 2m experimental profiles with seeding at 0 min: (a) solute concentration and 











Figure 5.6 PVM images (scale bar 100 µm) from Run 2m at: (a) 41 min, at first detection of 

























































































Figure 5.7. Run 4m experimental profiles with seeding at 0 min: (a) solute concentration and 








Figure 5.8 PVM images (scale bar 100 µm) from Run 4m: (a) at 43 min, onset of increase in 




























































































Figure 5.10 Supersaturation profiles implemented in the seeded batch crystallization runs. 
 
5.3.2  Concentration Controlled Batch Crystallization 
Three seeded crystallization experiments at various supersaturation profiles were 
implemented with concentration feedback control (Figure 5.10). Run 1 was 
implemented at a constant supersaturation (∆Ca = 0.00200 g/g solvent) that was very 
close to the metastable limit (determined using FBRM) while exceeding the onset zone 
of cross nucleation. The increase in the total counts/sec (Figure 5.11b), which starts at 
36 min at about 30.3°C, was attributed to the nucleation of the anhydrate form since 
the monohydrate needles was not detected via PVM images until about 104 min at 
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supersaturation profile did not cross the onset zone of cross nucleation at this point was 
likely due to increased surface area (and hence higher overall cross nucleation rate). 
Microscopy images of the seed (Figure 5.13a) and product crystals from Run 1 (Figure 
5.13bc) show that the needles agglomerated upon filtration (Figure 5.13c), such that 
individual needles were not well dispersed in the dried product sample compared to the 
slurry. The needles were observed on anhydrate crystal surfaces (Figure 5.13b) while 
anhydrate crystals smaller than the seed size were also detected (Figure 5.14). The 
amount of the monohydrate form in the product crystals estimated from PXRD (Figure 

















Figure 5.11 Experimental profiles in the seeded batch crystallization runs (with seeding at 0 
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Figure 5.12 PVM images (scale bar 100 µm) from Run 1 at (a) 36 min, onset of increase in 
FBRM total counts, (b) 104 min, first detection of monohydrate form crystals, (c) 243 min, and 







































Figure 5.13 Microscopy images of seed and product crystals (scale bar 200 µm, unless stated 
otherwise): (a) seeds – anhydrate form, (b) Run 1 products – monohydrate form crystals 
observed on the anhydrate crystals surfaces, (c) Run 1 products – agglomerates of 




















Figure 5.14 Size distribution of 100 L-phe anhydrate form seed and product crystals (based on 









Figure 5.15 PXRD patterns of seed and product crystals. 
 
 
Table 5.5 PXRD analysis of seed and product crystals. 
 
Sample 
Estimated solid composition (wt% 
monohydrate, ±1.81)* 
Seeds 1.09, 0.00; average = 0.55 
Run 1 products 8.03, 10.86 ; average = 9.45 
Run 2 products 1.06, 0.00;  average =  0.53 
Run 3 products 0.00, 1.14; average = 0.57 
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Run 2 was implemented with a smaller constant supersaturation (∆Ca = 0.00150 
g/g solvent), which was within the metastable limits throughout the run (Figure 5.10). 
The total counts/sec profile (see Figure 5.11b) showed a slight increase towards the 
end at 381 min (at 25.3°C). The supersaturation profile was near the onset zone which 
suggested that the cause of the increase was cross nucleation. A small number of 
monohydrate needles was detected in the PVM images (Figure 5.16b) prior to this at 
291 min (at about 27.6°C). The initial number of needles nucleated was sufficiently 
low such that it took ~90 min before cross nucleation was substantial enough to be 
detected by FBRM. Figure 5.13d shows the product crystals of Run 2 which consisted 
of anhydrate crystals of more uniform size (Figure 5.14). The monohydrate needles, 
however, were not readily observed in the microscopy images, and the characteristic 
peaks of this form were also absent in the PXRD pattern of the product crystals (Figure 
5.15). Cross nucleation, although detected in situ, did not produce a large enough mass 







































Figure 5.16 PVM images (scale bar 100 µm) from Run 2: (a) at 40 min, (b) at 291 min; first 
detection of monohydrate form crystals, and (c) at 381 min; onset of increase in total 
counts/sec. 
 
A disadvantage of the recipes in Runs 1 and 2 was that, by keeping the 
supersaturation with respect to the anhydrate form constant, the supersaturation with 
respect to the monohydrate was slowly increasing. This provided an increasing 
tendency for cross nucleation as the experiment progressed. A better approach to 
prevent cross nucleation is to maintain a low supersaturation with respect to the 
monohydrate form while growing the anhydrate form. Run 3 was implemented with 
constant supersaturation with respect to the monohydrate solubility (∆Cm = 0.00110 
g/g solvent); this translated into a varying driving force for the anhydrate form ranging 
from approximately 0.00190 to 0.00070 g/g solvent. This recipe was selected such that 
the supersaturation was less than that of Run 1 from 30.3°C onwards, to avoid 
secondary nucleation of the anhydrate form, and was below that of Run 2 from 27.6°C 





significant cross nucleation as shown by the constant total counts/sec (Figure 5.11b) 
and the absence of the monohydrate needles in the PVM images (Figure 5.17) 


















Figure 5.17 PVM images (scale bar 100 µm) from Run 3: (a) at 40 min, (b) at 300 min, and (c) 
at 400 min. 
 
 
Run 3 provided the best batch recipe in terms of high polymorph purity (Table 5.5) 
and relatively narrower size distribution of the anhydrate form products (Figures 5.13e 
and 5.14). Other means of selective crystallization, for example using solvent-mediated 
transformation (Hu et al., 2005; Maruyamaa et al., 1999; Starbuck et al., 2002; Qu et 
al., 2006; Caillet et al., 2006) of the metastable monohydrate form above the transition 
temperature (which was used to obtain the anhydrate seeds), led to a wider size 
distribution of the anhydrate form crystals.  
The cross nucleation detected in Runs 1 and 2, even though the supersaturation 




limit described a practical upper bound of the operating regime in the initial stages of 
crystallization, but less so as the experiments progressed due to the effect of increasing 
crystal mass on promoting secondary nucleation. The cooling rate used in the initial 
stages (prior to seeding) in the batch crystallization runs was similar to that in the 
metastable limit experiments. However, upon seeding and starting concentration 
feedback control, the cooling rates (Figure 5.11a) ranged from 0.03-0.04, 0.02-0.03, 
and 0.02 °C/min for Runs 1, 2, and 3, respectively.  
As the experiment progressed, there was increasing dissimilarity in the operating 
conditions (specifically the mass of the solid phase and the cooling rate) between the 
metastable limit experiments and the concentration controlled runs, and the upper 
bounds identified in the former were no longer representative of the actual conditions 
in the latter. Nonetheless, appropriate batch crystallization recipes can be designed 
systematically based on constant ∆Cm and using the results of earlier ∆Ca recipes as a 
more appropriate indication of the upper bound to effectively prevent secondary 
nucleation in the later stages of the operation. 
 
5.4  Concluding Remarks 
In this chapter, a batch recipe for the selective crystallization of the metastable 
anhydrate form of an enantiotropic pseudo-dimorph system, L-phenylalanine in a 
mixed solvent system (75 wt% water and 25 wt% 2-propanol), was identified as a 
desired trajectory in the phase diagram. The solubility curves of both pseudo-dimorphs 
were determined using ATR-FTIR spectroscopy combined with chemometrics. Laser 
backscattering was used to determine the seeded metastable limit, and the nucleated 
forms were identified using in situ video microscopy. Metastable limit determined to 
suppress uncontrolled secondary nucleation of either form defined the maximum 
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allowable supersaturation for operations. Batch crystallization implemented at low 
constant absolute supersaturation with respect to the monohydrate form suppressed 
cross nucleation and was successful in selectively growing large anhydrate crystals of 
relatively uniform size to temperatures below the transition point, where the anhydrate 
form is metastable. Similar operations stopping above the transition temperature, 
where the anhydrate form is stable, would simplify preferentially growth of anhydrate 
crystals but would have limited product yield. This methodology for the selective 
growth of metastable crystals extended the useful range of the phase diagram to 

















6  ESTIMATION OF KINETICS FOR L-PHENYLALANINE 
HYDRATE AND ANHYDRATE CRYSTALLIZATION 
 
6.1 Introduction 
While the approach demonstrated in Chapters 3 and 5 robustly produces the 
desired polymorph without requiring identification of the kinetics for crystal 
nucleation or growth, the kinetics are useful for further optimization of the operating 
conditions, specifically to elucidate the combined effect of operating variables such as 
the temperature profile, antisolvent addition rates, and seeding conditions, and well as 
crystallizer baffling, mixing blade design, and feed pipe location (Woo et al., 2006). In 
addition, process models of polymorphic crystallization facilitate the understanding of 
the relative importance of various competing crystallization mechanisms, such as 
different mechanisms for secondary nucleation. 
This paper describes the staged parameter estimation to model the nucleation and 
growth of L-phenylalanine (L-phe) crystals in propanol-water solution. The 
crystallization model includes kinetic parameters for both the anhydrate and 
monohydrate forms estimated from in situ experimental data from Chapter 5, 
specifically, the solute concentration measured using Attenuated Total Reflection-
Fourier Transform Infrared (ATR-FTIR) spectroscopy and moments of the chord 
length distribution (CLD) obtained using Focused Beam Reflectance Measurement 
(FBRM). The staged approach enables individual sets of kinetic parameters to be 
estimated, as opposed to the simultaneous estimation of all kinetic parameters. The 
predictive ability of the model was evaluated based on comparisons with offline 
characterization of the product crystals as well as with the experimentally determined 
metastable limits.  
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The transformation rate of the anhydrate to the monohydrate form in water below 
the transition temperature has been monitored previously based on offline powder X-
ray diffraction (PXRD) analysis (Mohan et al., 2001). For anhydrous seeds with typical 
size 100 µm, the induction time of the monohydrate form is reported to be 3 and 22 
hours at 15°C and 30°C respectively. The time for complete transformation was 
typically three times of the induction period. More recent studies on monitoring 
polymorphic crystallization and transformation of other organic compounds utilized in 
situ instruments such as ATR-FTIR and Raman spectroscopy, which have been applied 
in monotropic and enantiotropic systems (Wang et al., 2000; Groen and Roberts, 2001; 
Starbuck et al., 2002; Hu et al., 2005; Qu et al., 2006; Caillet et al., 2006). In situ 
process monitoring and modeling with kinetics estimation have been applied to L-
glutamic acid, (Ono et al., 2004a; Scholl et al., 2006; Hermanto et al., 2008) a 
monotropic dimorph system. Similar transformation analysis has been applied to the 
enantiotropic pseudo-dimorph of citric acid (Caillet et al., 2007), but only pertaining to 
the dissolution of the metastable form and nucleation and growth of the stable form. To 
the best of the authors’ knowledge, this is the first comprehensive polymorphic 
crystallization study for an enantiotropic system, which includes in situ monitoring and 
parameter estimation of the nucleation and growth kinetics of both forms. Section 6.2 
describes the segmentation of the experimental data for parameter estimation, while 
Section 6.3 presents various aspects of the mathematical model for L-phe 
crystallization. Section 6.4 compares the staged approach utilized here to simultaneous 
parameter estimation.  A summary of the key findings is given in Section 6.5. 
 
6.2  Experimental Data for Modeling 
The seeded batch crystallization experiments (Runs 1, 2, and 3) from Chapter 5 
implemented using concentration feedback control were used for the parameter 
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estimation; Table 6.1 summarizes the operating conditions and results. The seeds were 
added at time t = 0 min. The anhydrate seeds for all three runs were from the same 
batch which had the size distribution shown in Figure 6.1 (sampled from 100 crystals, 
based on the largest distance across a crystal measurable from microscopy images, La 
[µm], which occurs along the diagonal). The size distribution for the anhydrate product 
crystals were similarly constructed (Figure 5.14). 
 










in the product 
crystals† 
1 
∆C a = 
0.00200 
detected, from t ≈ 36 
min  
detected, from t ≈ 104 
min 





detected, from t ≈ 291 
min 




not detected not detected 0.57 ± 1.81 
* for Run 2, the increase in the total counts/sec and the detection of the monohydrate needles 
from PVM images towards the end of the run were substantial experimental evidence of cross 
nucleation, although the amount of the monohydrate form in the product was below the 
detection limit using PXRD. 
† based on 95% confidence interval. 
 

























































The crystallization model for L-phe describing the nucleation and growth kinetics 
of both anhydrate and monohydrate forms contains a large number of kinetic 
parameters which are challenging to estimate simultaneously. In the above 
experiments, some kinetic phenomena were suppressed at certain segments of the 
experimental data, to reduce the number of kinetic parameters to facilitate efficient and 
accurate parameter estimation. The newly determined kinetics were then utilized in the 
next set of data to facilitate the estimation of the remaining kinetics. For example, the 
anhydrate form growth kinetics can be estimated from Run 3 and the first 0-275 min of 
Run 2 because nucleation of either form was not detected in these ranges (although 
cross nucleation was detected in Run 2 at 291 min, the data range was limited to 275 
min to ensure no hydrate crystals were in the system). The newly determined 
anhydrate growth kinetics was then incorporated into the analysis of the next segment 
of the experimental data, for example, to account for the effects of anhydrate form 
growth while estimating its nucleation kinetics from the first 100 min of Run 1. Both 
sets of kinetic parameters for the anhydrate form were then utilized in the analysis of 
the remaining experimental data while estimating crystallization kinetics of the 
monohydrate form. The implementation of experiments and parameter estimation in 
stages reduces the number of parameters to be estimated simultaneously and thus 
decreases the chance of obtaining poorly conditioned parameter estimation 
optimizations. Table 6.2 summarizes the segments of the experimental data relevant to 
the different kinetics. The development of the crystallization model along with the 







Table 6.2 Segments of experimental data pertaining to different crystallization kinetics. 
 
Crystallization kinetics Relevant experimental range 
anhydrate form growth Run 2 (0-275 min); Run 3 (entire duration) 
anhydrate form nucleation Run 1 (0-100 min) 
monohydrate form nucleation and 
growth 
Run 1 (100 min-end); Run 2 (275 min-end) 
 
6.3  Mathematical Model of L-phe Crystallization 
This section presents the mathematical model for the crystallization of L-phe. This 
was based on the population balance equation (PBE), coupled with the kinetic 
expressions for nucleation and crystal growth for both the anhydrate and monohydrate 
forms. The kinetic parameters were estimated using weighted least-squares regressions 
based on the results of the concentration controlled experiments. The model was then 
validated based on the offline characterization of the product crystals as well as 
metastable limit experiments. 
 
6.3.1  Model Equations  
The model is based on the assumption that the crystallizer is well-mixed, that is, no 
spatial variations in T, C, or CSD. Such assumptions are common in the industrial 
crystallization literature for a lab-scale crystallizer (Rawlings et al., 1993). The 
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,                            (6.1) 
 
i = anhydrate (a) or monohydrate (m) of L-phe, 
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where Li [µm] is the characteristic crystal dimension and L0,i > 0 is the characteristic 
size for nucleated crystals, T is temperature, Gi [µm/min] is the crystal growth rate 
along the characteristic dimension, Bi [# crystals/(min-g solvent)] is the nucleation rate, 
Si [-] is the relative supersaturation (C−Csat,i)/Csat,i,  δ(·) is the Dirac delta function, and 
θg,i and θb,i are sets of growth and nucleation parameters. The seed crystals consisted of 
pure anhydrate form. Thus the initial condition for the population balance is given by 
the CSD of the anhydrate seed crystals fa(La,0) with fm(Lm,0) = 0. Assuming that there 
is no mechanism for producing either form of crystals of size L0,i = 0 and that the 
initial distribution does not have anhydrate crystals of size La = 0, the boundary 
condition is 
  
(0, ) 0, (0, )if t t= ∀ ∈ ∞ .                     (6.2) 
 
Applying the method of moments, the population balance equations can be 
converted into the system of ordinary differential equations (ODEs) by multiplying 
both sides of equation 6.1 by L 
j, for j = 0, 1, 2, …, and integrating each term of 0 to ∞ 
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The CSD moments relate to the physical properties of the crystals in the 
distribution; µ0,i [# crystals/g solvent], µ1,i [(# crystals-µm)/g solvent], µ2,i [(# crystals-
µm2)/g solvent], and µ3,i [(# crystals-µm
3)/g solvent] are proportional to the total 
number, length, surface area, and volume of the crystals, respectively. The solute mass 
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µ ρ= +∑ ,                    (6.6) 
 
where ρi is the crystal density (ρa = 1.29×10
-12 g/µm3, ρm = 1.724×10
-12 g/µm3) and kv,i 
is the volumetric shape factor defined by 3,i v i iv k L= where vi is the volume of an i-form 
crystal. Values for vi [µm
3] were estimated from microscopy images of crystals of both 
forms, and kv,i subsequently calculated using La as the largest diagonal length and Lm as 
the thickness of the needle (kv,a = 0.0394 and kv,m = 5.77). The nucleated crystals were 
treated as being of negligible size L0,i → 0 (Rawlings et al., 1993; Randolph and 
Larson, 1988); using realistic nonzero values for L0,i gives essentially the same µj,i and 
C predictions because the terms that contain L0,i in the moment equations are many 
orders of magnitude smaller than the rest of the terms. For parameter estimation, µ0,i, 
µ1,i, and µ2,i were simulated for both forms, along with C, which are described by seven 
ordinary differential equations (ODEs, equations 6.3 and 6.4 for both forms and 
equation 6.6). Values for µ3,i were also simulated for comparison with the FBRM data.  
For the system of ODEs (equations 6.3 and 6.4), the initial conditions were 
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 +  = −   
∑ ,                                           (6.7) 
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where L1,a and LN,a refer to the minimum and maximum sizes (200 and 520 µm, 
respectively, from Figure 6.1). The superscript s indicates the quantity is based on a 
sample population of 100 crystals, 1, ,( ,0)
s
a k a k af L L+ −  [# crystals] is the number of 
crystals with sizes between Lk+1,a and Lk,a at time t = 0. In the model, µj,a (and µj,m) were 
expressed as per unit mass of solvent, while that calculated from equation 6.7 were for 
a sample of 100 crystals, e.g., 0, ( 0) 100.
s
a tµ = =  These quantities are related by a 




j a j aµ λµ= .            (6.8) 
 
The initial value for µ3,a can be calculated from mass balance: 
 
3, ,( 0)sd a v a a solvm t k mµ ρ= = ,                      (6.9) 
 
where msd [g] is the mass of seed crystals and msolv [g] is the solvent mass. The value 
for λ was then calculated by comparing 3, ( 0)
s
a tµ =  from equation 6.7 and µ3,a(t = 0) 
from equation 6.9. With λ known, the , ( 0)j a tµ =  were calculated from , ( 0)
s
j a tµ =  for j 
= 0, 1, and 2. The initial solute concentration, C(t = 0) = C0, was the value measured 
immediately after seeding. This study utilized the power law expressions for the 
nucleation and growth kinetic equations, which have been widely used for a large 
number of systems in literature (Rawlings et al., 1993; Randolph and Larson, 1988). 
Specifically, the growth rate of the anhydrate form, Ga, was assumed to be size 
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where ' ,g ak  [µm/min] and ga [-] are the parameters to be estimated. The Arrhenius 
relationship was used to account for the temperature dependence using   
 
,'
, , exp ( 273.15)
g a




  =    + 
,                  (6.11) 
where Eg,a [J/mol] is the anhydrate form growth rate activation energy, R [J/(mol-K)] is 
the gas constant, and ,g ak  has the same dimensions as 
'
,g ak . An expression for size-





a g a a aG k S Lγ= + ,                                  (6.12) 
 
where the constant γ  [1/µm] may be positive or negative (MacGillivray, 1980). Using 










µ γµ−= + ,     j = 1, 2, ...                              (6.13) 
 
The solute mass balance equation 6.6 was modified in the same manner. For the 





m g m mG k S= ,                                                                                     (6.14) 
 
where, analogous to that of the anhydrate form, kg,m [µm/min] and gm [-] are the pre-
exponential and exponential factors to be determined. In general, nucleation is 
classified into two categories, primary or secondary, for nucleation in the absence and 
in the presence of crystals, respectively. In this study, secondary nucleation from 
crystal surfaces was considered, as it is the dominant mechanism in seeded 
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where ' ,b ak  [1/(min-µm
2)] and ba [-] are the parameters to be estimated. Arrhenius 
temperature dependence was assumed: 
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  =   + 
,                         (6.16) 
 
where Eb,a [J/mol] is the anhydrate form nucleation rate activation energy and kb,a has 
same dimensions as ' ,b ak . The nucleation rate of the monohydrate form 
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m mb b




2)], b1,m [-], and b1,m [-] are the nucleation 
parameters to be estimated. This includes a self- and a cross-nucleation term (i.e., 
dependence on µ2,a) as the secondary nucleation of the monohydrate form on the 
surfaces of anhydrate crystals has been reported (Mohan et al., 2001). 
  
6.3.2  Relationship between CSD and CLD Moments  
The FBRM probe emits a laser beam which moves in a circular path at a high 
frequency using rotating optics. As the laser beam ‘crosses’ a particle, a chord length 
or a count is registered, i.e., a chord length is the distance across the crystal surface as 
observed by the laser beam. The CLD measured in situ is related to but not the same as 
the CSD. The model equations 6.3 and 6.4 utilize the CSD moments; these data are not 
available in real-time, but can be estimated from the measured CLD. Specifically the 
CSD is first recovered from the CLD before calculating its moments. Numerous 
previous works (Tadayyon and Rohani, 1998; Hukkanen and Braatz, 2003; Li et al., 
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2006) have studied how the CSD can be recovered from the measured CLD by 
geometric modeling. Additionally, the modeled relationship between the CLD and 








jµ −  is the (j-1)th moment of the CLD and jξ  is a shape-dependent scaling 
factor (a function of the single-particle CLD). These models require many assumptions 
(Kail et al., 2007), including perfect backscattering of the laser at all angles and that all 
particles have a known shape. While these may hold true for some particulate systems, 
these assumptions are not applicable for other systems, and will not be true for most 
pharmaceutical systems, in which the refractive indices of crystal and solution are 
similar. Furthermore, unmodeled factors such as the optical properties of solids and 
solvents, as well as positioning of the probe in relation to the surrounding flow, can 
significantly impact the CLD and subsequently the estimated CSD (Kail et al., 2007). 
An alternative approach is to use the low-order CLD moments, without first obtaining 
a CSD estimate; this replaces the first-principles model for the CSD with a gray-box 
model for the CLD, in which the structure of the first-principles model for the low-
order CSD moments is used to parametrize that of the CLD (Hermanto et al., 2008; 
Togkalidou et al., 2004). The low-order CLD moments should follow the same 
dynamic trends as the low CSD moments because the mapping between the CLD and 
CSD is static (most of the models mentioned earlier assume that the mapping is not 
only static but also linear). This study follows a modification of that approach to 
establish the relationship between the CSD and CLD moments. At any experimental 
time point, the solute mass balance can be written as  
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0 3, , 3, ,( )sd solv a a v a m m v m solvm C m k k C mµ ρ µ ρ+ = + + .                      (6.19) 
 
For Run 3, µ3,m was set to 0 because cross nucleation was not detected. Simplifying 
equation 6.19 and using the values of C determined in-situ from ATR-FTIR 
spectroscopy, µ3,a was calculated at various time points and compared to the second-, 
third-, and fourth-order CLD moments for the anhydrate form, 2,
c
aµ  [(# counts-
µm2)/sec], 3,
c
aµ  [(# counts-µm
3)/sec], and 4,
c
aµ  [(# counts-µm
4)/sec], respectively. The 
CLD moments were estimated based on the superposition principle in which both 
forms contribute additively to the overall CLD, i.e., , ,
c c c




















 +  = −  




L  and cNL  refer to the minimum and maximum chord lengths (1 and 1000 µm, 
respectively) and 1( )
c c c
k kf L L+ −  [# counts/sec] is the number of chord lengths between 
1
c
kL +  and
c
kL . In the absence of cross nucleation in Run 3, the CLD data were due solely 
to the anhydrate form; ,
c
j mµ  was set to zero and ,
c
j aµ  calculated directly from equation 
6.20. Each order of ,
c
j aµ  was scaled accordingly to give the best fit to µ3,a. In Figure 
6.2, 4,
c
aµ  shows the best fit to µ3,a; thus the relationship between CLD and CSD 




j a j a j aµ µ +=Φ ,                                                                                                        (6.21) 
 
where Φj,a [(# crystals-sec)/(# counts-µm-g solvent)] is a proportionality constant. The 
corresponding relationship for the monohydrate form is similar. The empirical 
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correlation (equation 6.21) differs from some theoretical predictions (equation 6.18). 
Recall that theoretical predictions are based on many restrictive assumptions that do 
not apply to all particulate systems. It is interesting that equation 6.21 is an expression 
commonly used in industrial practice (called “length-weighting”), whereas equation 








Figure 6.2 Comparison of the CSD moment µ3,a to various CLD moments. 
 
6.3.3  Parameter Estimation  
Equations 6.3, 6.4, and 6.6 describing the nucleation and growth of both forms of 
L-phe contain 12 parameters that were estimated using the in situ experimental data 
from Runs 1, 2, and 3. Specifically, the C profile recorded by ATR-FTIR spectroscopy 
and cjµ (for j = 1, 2, and 3) measured by FBRM were used. The kinetic parameters were 
estimated by minimizing the weighted difference between the experimental 














Ψ = −∑∑ ,                                                                      (6.22) 
 
where θ is the vector of the parameters to be estimated, Nv (= 4) is the number of 
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factor which is the inverse of an estimate of the error variance 2qσ . Initially, σq was set 
to the standard deviation of the actual measurement. A set of parameters was estimated 
by solving the system of ODEs (equation 6.3, 6.4, and 6.6) coupled with the 
optimization problem in equation 6.22, using the built-in Matlab codes ‘ode45’ and 
‘fmincon’ (Mathworks, Inc). The standard deviations for the errors in the qth measured 
variable were then estimated, and these new values used for σq and fed to the parameter 
estimation problem to be solved again. The iterative procedure was repeated until no 
significant difference between the given and estimated standard deviations was 
detected. 
The parameter estimation for the different sets of kinetics was carried out in stages. 
In Stage 1, the parameters for the anhydrate form growth were estimated first using the 
experimental data from Run 2 (up to 275 min) and Run 3 (for the entire experiment, 
see Tables 6.1 and 6.2). In these durations, both types of nucleation were not detected, 
and the characteristic evolution of C and ,
c
j aµ were solely due to the growth of 
anhydrate form crystals. Thus the system of ODEs was simplified by setting Ba, Bm, 
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Φ = ∑ .                                                                               (6.23) 
 




j aµ +  calculated from equation 6.21 
were used for weighted least squares regression in equation 6.22. Figures 6.3 and 6.4 
show very good agreement between the Stage 1 model and experimental data (lack of 
fit from 300 min onwards for Run 2 was due to cross nucleation and not yet accounted 

























Figure 6.3 Run 3 profiles, experimental (-); Stage 1 model (-): (a) 1
cµ , (b) 2
cµ , (c) 3






















































































































































































































Figure 6.4 Run 2 profiles, experimental (-); Stage 1 model (-); Stage 3 model (-): (a) 1
cµ , (b) 
2
cµ , (c) 3
cµ , (d) 4
































































































































































































































     + 
 kg,a; ga; Eg,a 3.953 9.983 3.848 




, exp (1 )( 273.15)
g a g






   +   + 
 
kg,a; ga; Eg,a; γ 3.946 2.840 3.848 
 
Although not utilized for regression, 3
mdµ  was also simulated, scaled, and compared 
to ,4
c exµ , as shown in Figures 6.3d and 6.4d. The agreement between the Stage 1 model 
and data is very good. Variants of the power law model for the anhydrate form growth 
were also investigated (see Table 6.3), along with the nominal model (equations 6.10 
and 6.11). The F-test was used to compare the first and second model based on the 
weighted sum of square residuals, Ψ1 and Ψ2, respectively. The F-test statistic is given 
by (Beck and Arnold, 1977) 
 
 1 2 ,2 ,1
2 ,2










,                           (6.24) 
 
where Nθ,2 and Nθ,1 are the number of parameters in the corresponding models, and Nt 
= 1424 is the total number of independent measurements from ATR-FTIR 
spectroscopy and FBRM. The values for F-critical listed in Table 6.3 are based on the 
rejection probability of 0.05, with (Nθ,2-Nθ,1, Nt-Nθ,2) degrees of freedom. As F > F-
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critical, the reduction in Ψ due to the additional parameter in model 2 is statistically 
significant. Similar analysis comparing models 2 to 3 indicated that the reduction in Ψ 
with the addition of the parameter, γ, for size-dependent growth was not statistically 
significant. Comparison of the CSD of the anhydrate seed and product crystals of Run 
3 in Figure 5.14 suggests some size-dependent growth because the latter has a wider 
spread. Nonetheless, the available in situ experimental data did not statistically justify 
the estimation of γ, possibly due to the noise in the CLD measurements. The noise 
level could be reduced by increasing the number of seed crystals (from the current seed 
loading at ~15%); but this would also reduce the amount of growth that occurs during 
the batch run, such that the overall signal-to-noise ratio is not significantly improved. 
In Stage 2 of the parameter estimation, the parameters for anhydrate form 
nucleation were determined from the experimental data from Run 1 (up to 100 min, 
where cross nucleation was negligible, see Tables 6.1 and 6.2). The same set of ODEs 
was used with Bm = Gm = 0 with the kinetics for Ga inserted. The proportionality 
constants Φj,a for the CLD moments were estimated in the same manner using equation 
6.23. Their values were nearly the same as in Stage 1, for example, Φ0,a was 0.487 and 
0.519 in the Stages 1 and 2, respectively. The minor discrepancy was likely due to 
slight variation in the crystal habit of the anhydrate seed crystals used in the different 
experiments. The Stage 2 model and experimental data show good agreement for the 
modeled time range (Figure 6.5, the lack of fit starting from 100 min onwards was 





























Figure 6.5 Run 1 profiles, experimental (-); Stage 1 and 2 models (-); Stage 3 model (-):  
(a) 1
cµ , (b) 2
cµ , (c) 3
cµ , (d) 4














































































































































































A simpler variant of the power model for the anhydrate form nucleation was also 
studied. Similar analysis using the F-test statistics (with Nt = 251 and F-critical based 
on the same rejection probability as before) indicated that the improvement in the fits 
between experimental data and the model was statistically significant with the addition 
of Eb,a to describe the temperature dependence (Table 6.4).   
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    + 
 kb,a; ba; Eb,a 3.967 7.722 3.879 
 
In Stage 3 of the parameter estimation, the parameters for both the nucleation and 
growth of the monohydrate form were determined using the relevant range of 
experimental data in Run 1 (100 to 200 min) and Run 2 (from 275 min onwards, see 
Tables 6.1 and 6.2). Although cross nucleation occurred in Run 1 from 100 min 
onwards, the modeled time range was restricted up to 200 min because preliminary 
modeling gave extremely poor fits in the CLD moments from about 200 min onwards. 
It was likely that the FBRM probe become partially clogged at increasingly high solid 
density of the monohydrate needles. In addition, despite the appearance of distinct 
individual needles in the PVM images, there was possible formation of agglomerates 
or ‘bundles’ which would give erroneous high counts of the chord length. The model 
for parameter estimation was the ODEs with the newly estimated kinetics for Ba and 
Ga to account for the nucleation and growth of anhydrate form crystals. The measured 
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CLD moments, , 1
c ex
jµ +  were due to both anhydrate and monohydrate forms. The rates Ba 








jµ +  were 
attributed only to the monohydrate form and were then used to estimate its kinetics. 








j m c ex c md
s n j n j a n
N
µ
µ µ= + +
Φ =
−
∑ .                  (6.25) 
 
 The model CLD moments , 1,
c md
j mµ + calculated from these Φj,m were used for 
regression in equation 6.22. Although not used in regression, 3,
md
mµ  was simulated and 
scaled to give ,4,
c md
mµ . Figures 6.4 and 6.5, shows good agreement between the model 
and experimental data for modeled range (the overall model CLD moments 
, , ,
1 1, 1,
c md c md c md
j j a j mµ µ µ+ + += + ). Although not used in the regression, 
,
4
c mdµ agreed well with 
,
4
c exµ in the modeled range (Figures 6.4d and 6.5d). As mentioned earlier, the lack of fit 
for the moment profiles in Run 1 starting from 200 min onwards was likely due to 
some clogging of the FBRM probe and possible formation of agglomerates. The model 
C profile in Figure 6.5e showed a poor fit to the experimental profile from 200 min 
onwards. This was similarly due to the progressively higher solids density of the 
monohydrate needles. In most cases, the penetration depth of the evanescent field 
(≈0.5-2.5 µm, for the experimental setup in this study) into the solution is smaller than 
the liquid phase barrier between the probe and the particles. Hence, when the ATR 
probe is inserted into a crystal slurry, the substance in immediate contact with the 
probe is nearly all liquid, with negligible interference from the crystals. However, in 
this specific case, the monohydrate needles were of dimensions comparable to the 
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penetration depth; although initially negligible at low solids density, the interference 
from this solid phase becomes increasingly significant as Run 1 progressed with the 
rising monohydrate form solids density. The kinetic expressions for the crystallization 
of the monohydrate form (equations 6.14 and 6.17) contain a total of 6 parameters to 
be estimated simultaneously, fairly larger than that for the anhydrate form. Unlike the 
anhydrate form growth kinetics which was determined from anhydrate form seeded 
experiments, it is difficult to reduce the number of estimated parameters for the 
monohydrate form by first evaluating its growth kinetics solely in a separate 
experiment using monohydrate seed crystals. This is because it is very difficult to 
estimate the CSD (and its moments) of the monohydrate seeds reliably, given its 
smaller dimensions (thickness typically 2-10 µm, see Figure 5.1b) and the tendency of 
the needles to agglomerate when in the dried state and ease of breaking during 
handling. Inaccurate estimation of CSD moments as the initial conditions in the system 
of ODEs will lead to unreliable models and kinetic parameters. The variants of the 
power law model for both the nucleation and growth of the monohydrate form were 
also not investigated. Incorporating the temperature dependence using the Arrhenius 
equation will lead to a total of 9 parameters, or more if the parameter describing size-
dependence growth is included as well. Simultaneous estimation of a large number of 
crystallization parameters results in a wide range of parameters that produce similar 
quality fit to the data with highly correlated uncertainty descriptions (Miller and 
Rawlings, 1994). 
Table 6.5 lists all the parameter estimates from Stages 1, 2, and 3. The growth 
exponent ranges from 1 to 2 for diffusion-limited and surface integration-limited 
growth, respectively; the estimates indicate that anhydrate form growth is likely be 
controlled more by the latter, while that of the monohydrate form has similar 
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dependence on both. In the secondary nucleation of the monohydrate form, the larger 
estimate for b1,m relative to b2,m suggests that nucleation on its own surfaces may have 
a stronger dependence on Sm compared to nucleation on anhydrate form crystal 
surfaces. 
 
6.3.4 Confidence Intervals for the Parameter Estimates 
Parameter uncertainties were estimated by linearization of the model (Beck and 
Arnold, 1977; Rusli et al., 2007) around the vector of the parameter estimates: 
 
* *( ) ( ) ( )md md JY Y Fθ θ θ θ≈ + − ,                   (6.26) 
 












,                    (6.27) 
 
Y
md is a vector of model outputs Cmd and ,c mdjµ  for j = 1, 2, and 3. The Jacobian was 
computed using central differences; this matrix contains the first derivative of the 
model outputs with respect to θ, arranged so that derivatives with respect to a 
particular parameter, θp, are in the same column. The parameter covariance matrix for 
the linearized problem is given by (Beck and Arnold, 1977) 
 
1 1T
J Y JV F V Fθ
− −= ,                        (6.28) 
 
where VY is the covariance matrix for Y
md. The 100(1-α)% confidence interval (Rusli et 
al., 2007) for each parameter is described by 
 
* *
1 / 2 , 1 / 2 ,( ) ( )p t pp p p t ppt N N V t N N Vα θ θ α θ θθ θ θ− −− − ≤ ≤ + − .                       (6.29) 
 
105 
which are listed in Table 6 for all parameter estimates. The FJ matrices from all three 
parameter estimation stages satisfied the identifiability condition (Beck and Arnold, 
1977),  
 
0TJ JF F ≠ ,                    (6.30) 
 
indicating that all of the parameters could be identified from the experimental data. 
 








Number of independent 
measurements, Nt 
Parameter estimation Stage 1: Anhydrate form growth 
ln kg,a 42.330 [41.6, 43.0] 
ga 1.760 [1.61, 1.91] 
ln Eg,a 11.472 [11.45, 11.49] 
1424 
Parameter estimation Stage 2: Anhydrate form nucleation 
ln kb,a 73.502 [71.0, 76.0] 
ba 1.952 [1.83, 2.08] 
ln Eb,a 12.301 [12.23, 12.37] 
251 
Parameter estimation Stage 3: Monohydrate form nucleation and growth 
ln kb1,m -2.295 [-2.58, -2.01] 
b1,m 2.502 [2.19, 2.82] 
ln kb2,m -10.200 [-10.8, -9.62] 
b2,m 1.998 [1.74, 2.25] 
ln kg,m 1.135 [0.96, 1.30] 
gm 1.497 [1.44, 1.55] 
584 
 
Further analysis was performed by evaluating the linear correlation matrix Rc 
which measures the degree of linear dependence between a pair of parameters, where a 
magnitude of 1 indicates perfect correlation and a value of 0 indicates no correlation. 
Whenever all the off-diagonal elements have magnitude exceeding 0.8, the estimates 
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are highly correlated and tend to be inaccurate. These correlation coefficients in Rc are 
given by (Beck and Arnold, 1977) 
 
1/2
, , , ,( )c ij ij ii jjR V V Vθ θ θ
−= .                     (6.31) 
 
The parameter covariance and correlation matrices for Stage 1 of the parameter 
estimation were 
       ln kg,a ga ln Eg,a  
  1.341×10-1 8.189×10-3 2.025×10-3  
Vθ =  8.189×10
-3 6.095×10-3 -1.939×10-4  
  2.025×10-3 -1.939×10-4 8.699×10-5  
 
  1.000 0.286 0.593  
Rc =  0.286 1.000 -0.266  
  0.593 -0.266 1.000  
The off-diagonal terms of Rc indicate that, while there is some correlation between 
parameter estimates, the correlations are not excessive. The correlations between 
parameter estimates in Stage 2 are comparable in magnitude: 
  ln kb,a ba ln Eb,a  
  1.577 3.620×10-2 2.725×10-2  
Vθ =  3.620×10
-2 4.047×10-3 -9.662×10-4  
  2.725×10-2 -9.662×10-4 1.259×10-3  
 
  1.000 0.453 0.612  
Rc =  0.453 1.000 -0.428  
  0.612 -0.428 1.000  
The matrices for Stage 3 are on the next page. While the off-diagonal elements of Rc 
do not exceed 0.8, some of the elements are very nearly that value. This was expected 
as the number of parameters estimated in Stage 3 is significantly larger than Stages 1 
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and 2. Correlation coefficients larger than 0.8 would likely occur if more parameters 
were estimated, which would occur by including the temperature dependence in the 
nucleation and growth expressions for the monohydrate form. 
  ln kb1,m b1,m ln kb2,m b2,m ln kg,m gm  
  2.115E-02 1.703E-02 -3.585E-03 5.024E-03 3.710E-03 -1.331E-03  
  1.703E-02 2.590E-02 7.046E-04 1.369E-02 1.101E-02 -1.319E-03  
Vθ =  -3.585E-03 7.046E-04 8.751E-02 2.584E-02 -6.108E-03 -8.402E-04  
  5.024E-03 1.369E-02 2.584E-02 1.675E-02 4.080E-03 -1.623E-03  
  3.710E-03 1.101E-02 -6.108E-03 4.080E-03 7.888E-03 5.434E-04  
  -1.331E-03 -1.319E-03 -8.402E-04 -1.623E-03 5.434E-04 7.416E-04  
 
  1.000 0.727 -0.083 0.267 0.287 -0.336  
  0.727 1.000 0.015 0.657 0.771 -0.301  
Rc =  -0.083 0.015 1.000 0.675 -0.232 -0.104  
  0.267 0.657 0.675 1.000 0.355 -0.461  
  0.287 0.771 -0.232 0.355 1.000 0.225  
  -0.336 -0.301 -0.104 -0.461 0.225 1.000  
 
6.3.5  Model Validation  
The crystallization model for L-phe was validated in two parts. The first compares 
the model prediction of the average size of the anhydrate crystals and the polymorph 
composition of the product crystals to offline measured data for Runs 1, 2, and 3. The 
second validation compares the metastable limit predicted from the model to that 
determined experimentally. 
A plot of the average size of the i-form crystals, Li = µ1,i/µ0,i, from the model 
indicates that the three runs covered a range of growth rates (Figure 6.6), which was 
required to estimate independent values for the growth exponents and pre-exponential 
factors. The associated polymorph composition is shown in Figure 6.7. The average % 
difference between the model and experimental anhydrate product size is about 11% 
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(Table 6.6), while polymorphic compositions had somewhat larger deviations. The 
product thickness Lm of the monohydrate form predicted by the model were about 5 µm 
(Figure 6.6b) which is consistent with that observed from the distinct individual 
monohydrate needles in a PVM image obtained towards the end of Run 1 (Figure 
5.12d). No comparison is shown for the CSD for the monohydrate needles in the final 
product due to their tendency to agglomerate when in the dried state and as ease of 
breaking during handling. It was very difficult to determine the CSD for the 
monohydrate form using offline microscopy; any experimental data estimated in this 
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Figure 6.7 Simulated polymorph composition (wt% monohydrate). The predicted mass of the 
solid phase for the i-form, µ3,ikv,iρimsolv, was used to calculate the polymorph composition from 
µ3,m kv,m ρm msolv/(µ3,m kv,m ρm msolv + µ3,a kv,a ρa msolv). 
 
 
Table 6.6 Comparison of simulated and experimental results: mean La and  
product composition. 
 
Run Simulation Experimental 
 Average size of anhydrate product crystals, µm 
1 524 597, bin range 540 - 630 
2 679 614, bin range 540 – 630 
3 690 621, bin range 540 - 630 
 wt% monohydrate of product crystals 
1 16.75 9.45±1.81 
2 4.50 0.53±1.81 
 
The experimental results were determined from independent offline 
characterization of sample product crystals, with the mean size computed from 
1, 0,/
s s
a aµ µ with ,
s
j aµ calculated from equation 6.7 applied to the anhydrate product size 
distribution in Figure 5.14 determined from optical microscopy.  
The second validation compares the model predictions to the results from seeded 
metastable limit experiments (Runs 1m to 5m; operating conditions listed in Table 
5.3). The anhydrate seeds were from the same group of crystals as used in Runs 1, 2, 
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equations 6.7, 6.8, and 6.9, and the same operating conditions were applied (seeding 
temperatures and temperature profiles) as in the experiments. The model and 
experimental C and 1
cµ (due to both anhydrate and monohydrate forms) have good 

























































































































































































































































cµ and C profiles for the metastable limit experiments, experimental (-); model (-):  
(a,b), Run 1m; (c,d), Run 2m; (e, f), Run 3m; (g,h) Run 4m; (i,j) Run 5m. 
 
The modeled metastable limit was determined by assessing the evolution of the 
number and mean size of the nucleated crystals. Experimentally, the onset of cross 
nucleation was evaluated using the PVM which has a detection limit ≈3 µm (Hukkanen 
and Braatz, 2003; Hukkanen and Smith, 2006). Considering the possible spread or 
distribution in Lm, the modeled metastable limit was determined when its mean size, 
µ1,m/µ0,m reached 2.5 µm (Figure 6.9a), slightly smaller than the experimental detection 
limit. In each of the five runs, the corresponding C and T were determined at the time 
point at which µ1,m/µ0,m reached this value. Figure 6.10a shows good agreement 





















































































































































ability of the model for the monohydrate form. For the anhydrate form, the system of 
ODEs was modified slightly before carrying out similar analysis as above. The 
nucleation rate Ba was set to zero in the original set of ODEs pertaining to the 
anhydrate form, so that this set of ODEs only described the growth of the anhydrate 
seeds. Another set of ODEs (equations 6.3 and 6.4) was incorporated to describe the 
nucleated anhydrate crystals. The model metastable zone for the anhydrate form 
determined in similar fashion (Figure 6.9b) as above was very narrow and inconsistent 
with the experimental results which were determined using FBRM (detection limit ≥ 1 
µm). Further analysis revealed that the corresponding increase in the model µ0,a was 
<0.5% from an initial value of 450 (Figure 6.9d). This indicated an exceedingly small 
number of nucleated anhydrate crystals, unlike the monohydrate form which had 
corresponding simulated values of µ0,m ranging from 2000 to 3000 (Figure 6.9c), when 
the simulated mean Lm = 2.5 µm. In this case, evaluating the predicted metastable limit 
based solely on the simulated mean size of the nucleated crystals will not yield realistic 
results comparable to experimental findings given the noise in the measured CLD 
moments and possible masking effect in delaying the detection of nucleation. Thus, a 
more suitable criterion is to apply a certain threshold for the increase in the model µ0,a 
(assumed to be 10% in this study) in which enough nuclei are produced to be detected 
by FBRM.  
The corresponding values of C and T were used to plot the model metastable limit 
for the anhydrate form in Figure 6.10b which shows good agreement to the 
experimental metastable limit. Given the arbitrary selection for the threshold increase 
in µ0,a, this analysis does not fully validate the crystallization model for the anhydrate 


























































































































































Figure 6.9 Simulated profiles for Run 1m (-), 2m (-), 3m (-), 4m (-), and 5m (-):  
(a) mean Lm (µm), (b) mean La (µm), (c) number of nucleated crystals (monohydrate form), 

























Figure 6.10 Comparison of experimental metastable limits by FBRM (   ) and PVM (    ) to 
simulated results: (a) at mean Lm 2.0 µm (   ) and 2.5 µm (   ), (b) at 10% (   ) and 20% (   ) 



















































































































6.4 Staged vs. Simultaneous Parameter Estimation  
Any person who has constructed a process model for a sufficiently complex system 
has used some sort of staged approach, in which simplified experiments are designed 
to enable the estimation of individual sets of parameters. One advantage of the staged 
approach is that numerical optimizations for equation 6.22 are more likely to converge 
to the global solution, due to the smaller number of parameters. The optimization in 
equation 6.22 is rarely convex for nonlinear dynamic processes with more than 10 
parameters, such as occur in polymorphic and pseudo-polymorphic crystallizations, in 
which case numerical optimization algorithms can converge to a local solution that 
may produce both a poor fit to experimental data and a model with poor predictive 
ability. Numerical optimization over three parameters such as in Stages 1 and 2 are 
more likely to converge to the global solution by numerical optimization, and could 
even be solved graphically by gridding over the kinetic parameters. 
Another advantage of the staged approach is that it reduces the effect of model bias 
on the initial sets of estimated parameters. To understand this argument, consider that 
all process models have limitations (Box, 1979; Denbigh, 1951; Aris, 1978; Denn, 
1986). For example, most crystallization models assume that a lab-scale crystallizer is 
well-mixed and that all crystals of a particular structure have exactly the same crystal 
shape, which are only approximations. Due to these limitations, parameters estimated 
by fitting data to the outputs of these models are biased (Ljung, 1987). A goal of 
process modeling is for this bias to be sufficiently small that the process model is 
accurate enough for its intended purposes (such as design). An advantage of the staged 
approach to experimental design is that the bias in the kinetic parameters associated 
with parameter estimation in an early stage is only affected by model assumptions for 
the crystallization phenomena occurring at that and earlier stages---not on model 
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assumptions associated with crystallization phenomena that only occur in later stages. 
Alternatively, the simultaneous estimation of parameters can produce very large 
biases. Actually, before applying the staged approach we attempted to simultaneously 
fit all parameters to all experimental data which resulted in poor fits to Stage 1 and 
Stage 2 data, as the simultaneous parameter estimation shifted those kinetic parameters 
to achieve a better fit to the remaining data. The staged approach also made it easier to 
identify the faulty data produced by the in situ ATR-FTIR and FBRM probes 
(discussed earlier). 
A weakness of the staged approach is that any biases in the parameter estimates at 
any particular stage will bias the parameter estimates in subsequent stages. Also, 
confidence intervals computed in subsequent stages (such as in Table 6.5) will 
underestimate the amount of uncertainty in the parameter estimates. These effects 
should be small in this study due to the small size of the confidence intervals in Stages 
1 and 2 (see Table 6.5). While the effects of uncertainties on parameter estimates in 
one stage on the uncertainty in parameter estimates on subsequent stages can be 
quantified using similar techniques (Ma and Braatz, 2001; Nagy and Braatz, 2004; 
Matthews and Rawlings, 1998), these methods rely on the underlying model structure 
being known and fully characterized mathematically, which is not true in the presence 
of model bias. For these reasons, it is important to evaluate model predictions by 
comparing with experiment data collected from a separate set of experiments (as done 
here). 
Note that the staged experimental designs implemented here are very different 
from the D-optimal designs that have been applied extensively to non-polymorphic 
crystallizations (Miller and Rawlings, 1994; Togkalidou et al., 2004; Matthews and 
Rawlings, 1998; Chung et al., 2000). D-optimal design can result in experimental 
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designs in which all crystallization phenomena occur simultaneously, forcing the 
simultaneous estimation of all of the parameters. It should be possible, however, to add 
constraints in the crystallization phase diagram to the D-optimal approach so that 
staged experimental designs can be implemented that minimize the uncertainties in the 
parameters while retaining the advantages of stage design. This would combine the 
best features of the two approaches. 
 
6.5  Concluding Remarks 
A process model for the polymorphic crystallization of L-phenylalanine, an 
enantiotropic pseudo-dimorph system, was developed. The kinetic parameters for 
nucleation and growth for both the anhydrate and monohydrate forms were estimated 
using in situ probes (solute concentration obtained from ATR-FTIR spectroscopy and 
CLD moments measured using FBRM) from experiments in which feedback 
controlled motion in the crystallization phase diagram suppressed certain kinetic 
events (for example, cross nucleation) in particular segments of the experimental data. 
This simplified the crystallization model and reduced the number of parameters to be 
estimated simultaneously, by focusing on the relevant segments of the experimental 
data pertaining only to certain kinetics. This facilitated the estimation of the parameters 
in a stage-wise manner for each set of kinetics. Such an approach is advantageous for 
crystallization models with a large number of parameters such as for polymorphic 
systems. The predictive ability of the crystallization model was evaluated based on the 
model properties of the product crystals and metastable limit which were in good 
agreement with that from independent characterization and experiments. It is hoped 
that this combination of experimental design and process modeling will facilitate 
process modeling and development for other polymorphic pharmaceutical compounds.  
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7  CONCLUSIONS AND RECOMMENDATIONS 
 
7.1  Conclusions 
 The following conclusions are drawn based on the research work and results 
presented in this thesis: 
• A systematic methodology is presented for the selective crystallization of the 
metastable form of a monotropic dimorph, L-glutamic acid, for batch cooling 
crystallization. Attenuated Total Reflection-Fourier Transform Infrared (ATR-
FTIR) spectroscopy coupled with chemometrics was used to determine the 
solute concentration and solubility curves of both α and β-forms of L-glutamic 
acid in aqueous solution. The metastable limit associated with secondary 
nucleation for a seeded system was determined using laser backscattering 
(Focused Beam Reflectance Measurement, FBRM). Batch crystallizations 
seeded with the metastable α-form crystals following various preset 
supersaturation profiles were implemented using concentration feedback 
control which regulated the cooling rate based on in situ measurement of solute 
concentration. Batch crystallizations operated at constant relative 
supersaturation in an appropriate temperature range prevented secondary 
nucleation of both polymorph types and were successful in selectively growing 
large metastable crystals with uniform size. 
• The same direct design approach was applied to different polymorphic system; 
a batch recipe for the selective crystallization of the metastable anhydrate form 
of an enantiotropic pseudo-dimorph system, L-phenylalanine (L-phe), in a 
mixed solvent system (75 wt% water and 25 wt% 2-propanol) was 
implemented by controlled tracking of a designed trajectory in the phase 
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diagram. The solubility curves of both the anhydrate and monohydrate forms 
and the seeded metastable limit were determined in similar fashion using ATR-
FTIR spectroscopy and FBRM respectively. The nucleated forms identified 
using in situ video microscopy. Anhydrate form seeded batch operations were 
implemented following various preset supersaturation profiles; undesired 
secondary nucleation of both forms at the metastable limit provided the 
operating constraints in terms of the maximum allowable supersaturation. 
Batch crystallization implemented at low constant absolute supersaturation 
with respect to the unwanted monohydrate form was successful in preventing 
cross nucleation and in selectively growing large anhydrate crystals with 
relatively more uniform sizes. This methodology extended the useful range of 
the phase diagram to temperatures below the transition point, where the 
anhydrate form is metastable, to increase product yield compared to operations 
utilizing only the temperature range above the transition temperature, where 
this form is stable. 
• A semi-automated procedure for measuring the solubility of both enantiotropes 
in a dimorphic system was developed using the same in situ instruments. The 
approach was demonstrated for L-phe. The procedure involves the 
determination of the anhydrate form solubility from in situ IR spectroscopy of 
an equilibrated slurry, followed by the dissolution of the anhydrate form by 
heating. The monohydrate form is then recrystallized, and its solubility 
determined from slow heating until complete dissolution is detected by FBRM. 
The solubility of the monohydrate form was determined differently from the 
anhydrate form due to the interference on the IR measurements from small 
needle-like monohydrate crystals. This single-experiment approach allows for 
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more efficient solubility measurement of both forms and is applicable to other 
enantiotropic dimorph systems 
• A process model for the crystallization of L-phe crystals from mixed propanol-
water solution, an enantiotropic system, is developed with kinetics estimated 
for the anhydrate and monohydrate forms using in situ ATR-FTIR 
spectroscopy and laser backscattering. A challenging aspect of estimating 
kinetics for this system is the formation of large numbers of small crystals 
under certain conditions, which result in biases in the data collected from in 
situ ATR-FTIR and FBRM probes. Batch experiments were designed to follow 
particular trajectories in the phase diagram so that some kinetic phenomena are 
suppressed (for example, cross nucleation) in some runs, which enabled the 
estimation of sets of kinetic parameters in stages, reducing the number of 
parameters to be estimated simultaneously. The model was validated by 
comparison of model predictions and experiments for the product crystals and 
metastable limits obtained from independent characterization and experiments. 
It is hoped that this combination of experimental design and process modeling 
will be emulated to facilitate process modeling and development for other 
polymorphic pharmaceutical compounds. 
 
7.2  Recommendations for Future Work 
The successful demonstration in using the direct design approach applied with 
Process Analytical Technology (PAT) for the control, design and modeling of 
crystallization processes in non-polymorphic and dimorphic systems highlights its 
potential and applicability for more complex operations. Selective crystallization 
processes in multiple polymorphs systems and enantioseparation processes are of 
particular importance in the pharmaceutical industry. PAT has not yet been rigorously 
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applied in these systems because of their inherent complexity; it is expected that the 
implementation of more advanced modeling and control strategies will have a large 
impact. Example applications on such systems will be highly beneficial, particularly 
for industrial users.    
• Stearic acid is an example of a multiple polymorph system. It is applied to 
many industrial processes such as detergent and insulation industries and also 
for suppositories, coating enteric pills and ointments (Mirmehrabi and Rohani, 
2004); it is often considered a model compound in the series of long-chain 
compounds (Sato and Boistelle, 1984). Stearic acid has four known 
polymorphs, A, B, C, and E; polymorph A is triclinic, whereas forms B, C and 
E are monoclinic (Sato and Boistelle, 1983; 1984). The crystals of form A are 
elongated, while the B and C forms are lozenge-shaped, exhibiting acute angles 
of 75° and 55° respectively. Previous studies on the relative stability of each 
form revealed the enantiotropic relationship of forms B and C; the transition 
point is at 32°C and form B is the stable polymorph below this temperature 
(Sato and Boistelle, 1984; Sato et al., 1985). Form A is always metastable 
throughout the given temperature range (18-40°C) (Sato et al., 1985; 
Beckmann et al., 1984). Earlier works in preferential crystallization of certain 
modifications identified suitable occurrence domains / operating conditions for 
primary nucleation of each polymorph in terms of the solvent, temperature, 
supersaturation, and stirring condition (Sato and Boistelle, 1983; 1984; Garti et 
al., 1980b).  
• Enantioseparation processes from solution are of large interest because more 
than 50% of pharmaceutical active substances are known to be chiral (Lorenz 
and Siedel-Morgenstern, 2002). Enantioseparation and racemate resolution are 
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frequently by means of crystallization methods, as there are the manual sorting 
of crystals (for conglomerates), resolution by entrainment (preferential 
crystallization), separation via diastereomic salt formation and crystallization 
from optically active substance. Earlier studies mapped out operational 
pathways for selective crystallization of (+)-(S)- or (-)-R-Mandelic acid 
(Lorenz and Siedel-Morgenstern, 2002) in water based on ternary phase 
diagrams (Lorenz and Siedel-Morgenstern, 2002; 2004; Lorenz et al., 2002). 
Recent demonstration in using polarimetry, refractometry, and density 
measurement for in situ monitoring of the resolution progress of threonine 
(Elsner et al., 2005; Rodrigo et al., 2004) supports the implementation of 
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